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Abstract 
Fibroblast growth factor (FGF) signalling is critical for the initiation and regulation of multiple 
developmental processes including gastrulation, mesoderm induction and limb development. 
Despite extensive understanding of FGF signal transduction via tyrosine kinase receptors (RTKs), 
the specific mechanism responsible for regulation of target gene transcription is still not fully 
understood.  
The protein Capicua (CIC) has been linked to transcriptional regulation in RTK signalling via the ERK 
pathway in multiple organisms. ERK signalling cascades also mediate wound signal transduction and 
transcription of associated genes. We hypothesise that transcription of a subset of FGF target 
genes, and genes involved in the wound response, rely on ERK mediated relief of CIC transcriptional 
repression. 
The aims of this project were to establish if CIC operates downstream of FGF signalling through 
analysis and validation of RNA-seq data, and to investigate the relationship between CIC and ERK in 
FGF signalling and wound healing in Xenopus embryos.  
The work in this thesis shows that CIC knockdown and FGF overexpressing embryos exhibit similar 
phenotypes and transcriptomes. Immunostaining for myc-tagged CIC indicates that CIC expression 
is reduced following activation of FGF signalling or the wound response. 75% of the putative CIC 
and FGF regulated genes analysed have enriched CIC binding sites and 75% were upregulated in RT-
PCR analysis of CIC knockdown and FGF overexpressing embryos. Additionally, genes associated 
with wound healing (fos and gadd45a) are upregulated in CIC knockdown embryos. These data 
support the notion that CIC has a transcriptional regulatory role for a subset of FGF target genes 
and genes involved in the wound response.  
Misregulation of the FGF signalling pathway and/or CIC repression is associated with a range of 
disorders and cancers. Consequently, understanding the molecular mechanisms involved in these 
pathways may allow development of more effective treatments for injury, neurodegenerative and 
developmental disorders, and cancer. 
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Chapter 1: Introduction 
1.1 The fibroblast growth factor family 
Fibroblast growth factor (FGF) signalling is critical for the initiation and regulation of multiple 
developmental processes including gastrulation, mesoderm induction and limb development 
(Rossant et al., 1997; Slack et al., 1996; ten Berge et al., 2008). FGFs also play essential roles in injury 
and tissue repair and regeneration in the adult (Maddaluno et al., 2017). In vertebrates, the FGF 
ligand family has 22 members which can be categorised into 7 phylogenetic subfamilies (Ornitz, 
2000). These subfamilies can also be further classified into 3 groups: intracellular (FGF11-14), 
endocrine (FGF19, 21 and 23) and canonical (FGF1-10, 16-18, 20 and 22) (Itoh, 2010). Intracellular 
FGFs have high sequence homology with the FGF family but are not secreted and do not activate 
FGF receptors (FGFRs) (Beenken and Mohammadi, 2009). The canonical FGFs share a conserved 
core of 140 amino acids, have a strong affinity for heparin sulphate proteoglycans (HSPGs), and 
signal through the FGFR family of tyrosine kinase receptors (Dorey and Amaya, 2010). Endocrine 
FGF ligands target cells through the bloodstream and bind Klotho molecules as co-factors for 
receptor binding rather than HSPGs (Ornitz and Itoh, 2015). 
1.2 The fibroblast growth factor receptor family 
FGFR1, 2, 3 and 4 are composed of a single transmembrane domain, an intracellular domain with 
tyrosine kinase activity, and an extracellular ligand binding region (Böttcher and Niehrs, 2005). 
Immunoglobulin-like domains Ig1, Ig2 and Ig3 in the extracellular region are important for ligand 
and co-factor binding, receptor dimerisation, and ligand specificity as different isoforms of FGFR1-
3 are generated through alternate splicing of Ig3 (Table 1) (Johnson et al., 1991). Binding specificity 
is primarily regulated by alternative splicing of exons IIIb and IIIc of the C-terminal half of Ig3. For 
example, FGFR2 and FGFR3 exclusively express the IIIb exon in epithelial cells and IIIc in 
mesenchymal lineages (Scotet and Houssaint, 1998; Wuechner et al., 1996). Ig2 also contributes to 
FGF ligand and receptor specificity as it rotates to form a greater number of contacts with ligands 
such as FGF10 in a ligand-induced conformation change (Yeh et al., 2003). In this manner, FGF 
signalling is tightly regulated in order to ensure correct embryonic development and adult tissue 
homeostasis. Misregulation of the FGF signalling pathway can lead to a wide range of disorders 
including skeletal abnormalities, hypophosphatemic rickets and deafness (Beenken and 
Mohammadi, 2009). FGFR mutations in particular are associated with a number of cancers as FGF 
signalling is important in regulating cell proliferation and angiogenesis (Turner and Grose, 2010).  
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In addition to the 4 classical tyrosine kinase receptors, FGFR-like (FGFRL) also has a strong affinity 
for FGF ligands but lacks a tyrosine kinase domain (Trueb et al., 2003). The receptor is otherwise 
structurally similar to FGFR1-4 and was initially thought to function only as a decoy receptor to 
further modulate FGF signalling (Steinberg et al., 2010). However, overexpression of FGFRL leads to 
increased ERK signalling, thus suggesting that the receptor may also act as a non-tyrosine kinase 
signalling molecule (Ornitz and Itoh, 2015).  
FGFR isoform Ligand specificity 
FGFR1b FGF1, 2, 3, 10, 22 
FGFR1c FGF1, 2, 4, 5, 6, 19, 20, 21 
FGFR2b FGF1, 3, 4, 6, 7, 10, 22 
FGFR2c FGF1, 2, 4, 5, 6, 8, 9, 17, 18, 19, 21, 23 
FGFR3b FGF1, 9 
FGFR3c FGF1, 2, 4, 8, 9, 17, 18 19, 21, 23 
FGFR4 FGF1, 2, 4, 6, 8, 9, 16, 17, 18, 19 
FGFRL FGF2, 3, 4, 8, 10, 22 
Table 1: Ligand specificity of the fibroblast growth factor receptor family (Tiong et al., 2013; 
Steinberg et al., 2010)  
1.3 Canonical fibroblast growth factor signal transduction 
Binding of FGF and accessory molecule HSPG to FGFR1-4 leads to receptor dimerisation and 
autophosphorylation of intracellular tyrosine kinase domains (Schlessinger, 2000). This leads to 
further tyrosine phosphorylation within the receptor to create docking sites for secondary 
messengers. Phosphotyrosine residues bind Src homology 2 (SH2) domains found in various 
signalling proteins, allowing recruitment and activation of signalling complexes (Pawson et al., 
1993). FGF signal transduction proceeds via 3 main pathways: the phospholipase Cγ (PLCγ), 
phosphoinositide-3 (PI3) kinase or extracellular signal-regulated kinase (ERK) pathway (Figure 1).  
Binding of PLCγ to an FGFR phosphotyrosine residue at position 766, activates the enzyme leading 
to hydrolysis of phosphotidylinositol-4,5-diphosphate to inositol-1,4,5-trisphosphate (IP3) and 
diacylglycerol (DAG) (Peters et al., 1992). IP3 stimulates intracellular calcium release and DAG 
activates protein kinase C. This FGF signal transduction pathway is required for the modulation of 
planar cell polarity needed for cell movements during gastrulation (Sivak et al., 2005). 
FGF signalling can also activate the PI3 kinase pathway through Frs2 (FGFR substrate 2) binding 
Gab1 (growth factor receptor bound protein 2-associated-binding protein 1) indirectly via Grb2 
(growth factor receptor bound protein 2). Phosphorylation of Gab1 leads to the subsequent 
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recruitment and activation of PI3 kinase and downstream effector proteins (Ong et al., 2001). 
AKT/protein kinase B is an important downstream mediator of this pathway and is a proto-
oncogene involved in regulating cell survival and growth (Nicholson and Anderson, 2002).  
The most common FGF signalling pathway in development involves association of Frs2 with the 
activated receptor (Kouhara et al., 1997). This allows assembly of the protein complex required for 
initiation of the ERK signalling cascade (Hadari et al., 2001). Frs2 recruits the adaptor protein Grb2 
which in turn binds the guanine nucleotide exchange factor son of sevenless (Sos) via its Src 
homology 3 (SH3) domain (Ong et al., 2000). Sos promotes dissociation of GDP from small GTP 
binding protein Ras to allow its conversion to the active GTP-bound form. Activation of Ras leads to 
a cascade of sequential phosphorylation of transducing proteins Raf, Mek and ERK (also known as 
MAPK) (Schlessinger, 2000). Activated serine/threonine kinase ERK induces expression of target 
genes by directly phosphorylating transcription factors or by phosphorylating and activating other 
kinases to do so.  
 
Figure 1: Schematic representation of FGF signal transduction via the PLCγ, PI3 kinase and ERK 
signalling pathways. Binding of extracellular fibroblast growth factors (FGFs) and accessory 
molecule heparin sulphate proteoglycan (HSPG) causes dimerisation of FGF receptors and 
autophosphorylation of intracellular tyrosine kinase domains. FGF signal transduction proceeds via 
3 main pathways: the phospholipase Cγ (PLCγ), phosphoinositide-3 kinase (PI3K) or extracellular 
signal-regulated kinase (ERK) pathway.  
1.4 Transcriptional regulation in the FGF signalling pathway 
Many FGF target genes have been identified through transcriptomic screens involving the 
comparison of wild type Xenopus with those in which FGF signalling had been impaired. For 
example, a microarray screen of Xenopus explants treated with SU5402, a specific FGFR1 inhibitor, 
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highlighted 38 genes positively regulated and 5 genes negatively regulated by FGF signalling (Chung 
et al., 2004). Inhibition of FGF signalling by dominant negative mutants of FGFR1 and FGFR4a led to 
the identification of 67 genes significantly upregulated and 16 genes significantly downregulated 
by FGF signalling in normal Xenopus laevis development (Branney et al., 2009).  
The caudal-related (Cdx) group of ParaHox genes are among the FGF targets downregulated in the 
presence of dominant negative FGFRs (Pownall et al., 1996; Isaacs et al., 1998; Branney et al., 2009). 
In vertebrates, the Cdx genes are required for normal antero-posterior patterning, and the 
specification and differentiation of gut endoderm (Beck and Stringer, 2010). Cdx1, Cdx2 and Cdx4 
are initially expressed in the early mesoderm surrounding the blastopore region in Xenopus 
gastrulation (Pillemer et al., 1998). Normal mesodermal Cdx gene expression requires FGF signal 
transduction via activation of ERK, in addition to FGF dependent wnt8 expression (Keenan et al., 
2006). Overexpressing FGF4 in late gastrula to late neurula Xenopus leads to an anterior extension 
of the Cdx4 domain and a subset of homeobox (Hox) genes resulting in a posteriorised phenotype 
(Pownall et al., 1996). 
Brachyury (Xbra) is another well-established target whose expression is upregulated when FGF4 is 
overexpressed (Isaacs et al., 1994). The T-box transcription factor is crucial for mesoderm and 
notochord development in vertebrates, as homozygous mice mutants fail to form these along with 
all posterior structures (Chesley, 1935). Xbra expression is also reduced in Xenopus embryos treated 
with SU5402 (Chung et al., 2004) or expressing dominant negative FGFRs (Isaacs et al., 1994). Xbra 
is part of a closed autocatalytic regulatory loop in the early mesoderm where FGF4 induced Xbra 
expression maintains FGF4 expression via positive feedback (Isaacs et al., 1994).  
FGF signalling is also mediated by E26 transformation-specific (ETS) transcription factors. The 
polyoma enhancer activator 3 (PEA3) subfamily (also known as ETS variant transcription factor 4 
(Etv4)) includes PEA3, Etv5 and Etv1. Members of this subfamily act as downstream effectors of 
FGF-Ras-ERK signalling (Garg et al., 2018). Transcription of PEA3 ETS factors is repressed by the 
protein Capicua (CIC) in the absence of modulation by activated ERK, p90RSK (p90 ribosomal S6 
kinase) and 14-3-3 proteins (Dissanayake et al., 2011). PEA3 and Etv5 expression closely correlates 
with that of FGF8 and FGF3, is lost in zebrafish embryos treated with SU5402 and is ectopically 
expressed in the presence of FGF8/3 coated beads (Raible and Brand, 2001). Additionally, 
knockdown of the PEA3 subfamily in zebrafish produced phenotypes resembling FGF deficient 
embryos and significantly decreased FGF target gene expression (Znosko et al., 2010). PEA3 and 
Ets2 have also been shown to mediate FGF signalling in a negative feedback loop by directly binding 
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Dusp6 (dual-specificity phosphatase 6) promoters to inactivate ERK (Ekerot et al., 2008; Znosko et 
al., 2010).  
MyoD (myoblast determination protein 1), another well-documented FGF target gene, encodes a 
basic-helix-loop-helix transcription factor able to induce differentiation of skeletal muscle cells 
through direct regulation of muscle-specific genes (Tapscott, 2005). Previous work has shown that 
treatment of Xenopus laevis animal caps with eFGF (also known as FGF4) directly activates Xenopus 
myoD (XmyoD) even in the presence of translational inhibitor cycloheximide (CHX) (Fisher, 2002). 
This indicates that activation of XmyoD by FGF is an immediate early response not requiring 
translation or transcription. CHX treatment alone activates some transcription of XmyoD suggesting 
that FGF target gene expression involves inhibition of a labile transcriptional repressor, the levels 
of which rapidly decay in the absence of protein synthesis. Expression of Cdx genes is also increased 
following CHX treatment of animal caps indicating that XmyoD is not the only FGF target likely to 
be regulated in this manner (Keenan et al., 2006). 
Other evidence for an unstable protein repressing FGF transcriptional target XmyoD includes the 
fact that following the midblastula transition, XmyoD is transiently expressed at a low level 
ubiquitously throughout the embryo (Rupp and Weintraub, 1991). This is quickly silenced, possibly 
due to zygotic gene activation and translation of a transcriptional repressor. The high levels of 
XmyoD necessary for myogenic development could then be achieved in specific cells through 
inactivation of the repressor by modification via FGF signalling. Furthermore, transfection of the 
myoD enhancer sequence fused to the chloramphenicol acetyltransferase (CAT) reporter gene into 
multiple cell lines significantly increases myoD expression. However, expression of the human myoD 
enhancer upstream of a lacZ reporter in transgenic mice results in intense staining of only skeletal 
muscle-forming regions. Transgene activation and endogenous myoD expression is restricted to 
limb buds and the myotomal compartments of somites in vivo. The difference between the myoD 
expression pattern in tissue culture and in vivo may be due to the presence of a transcriptional 
repressor necessary for silencing myoD in non-muscle cells within the embryo which is not present 
in derived cell lines (Goldhamer et al., 1992).  
1.5 The transcriptional repressor Capicua and ERK signalling 
High mobility group box protein Capicua (CIC) has been identified as a transcriptional repressor 
potentially involved in regulating expression of FGF gene targets.  
CIC has been linked to transcriptional regulation in receptor tyrosine kinase (RTK) signalling via the 
ERK pathway in multiple organisms including mice and humans (Jimenez et al., 2012). In all cases 
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studied, binding of CIC to target protein promoters and enhancers leads to transcriptional 
repression in the absence of RTK signalling. For example, Torso is a tyrosine kinase receptor 
activated at the anterior and posterior poles of the Drosophila melanogaster syncytial embryo, 
where its ligand Trunk is produced. This creates a gradient of ERK activity at each embryonic pole. 
Phosphorylation of CIC by activated ERK (diphosphorylated ERK (dpERK)) leads to degradation of 
CIC, thus creating an opposing gradient of CIC protein levels decreasing towards the pole (Jimenez 
et al., 2000). This allows transcription of huckebein (hkb) and tailless (tll). CIC represses hkb more 
effectively than tll, leading to a narrower, nested hkb expression profile required for the 
differentiation of terminal region structures (Duffy and Perrimon, 1994). At the anterior terminus, 
CIC is also involved in establishing posterior boundaries of Bicoid target genes through binding of 
Bicoid responsive enhancers (Löhr et al., 2009) 
CIC has also been shown to act as a vital regulatory switch in RTK signalling in the Drosophila ovarian 
follicle where EGFR signalling induces nuclear export and partial relocalisation of CIC to the 
cytoplasm following phosphorylation by ERK. CIC is important in establishing the dorsoventral axis 
as it represses homeodomain transcription factor Mirror in ventral follicle cells, thus allowing pipe 
transcription (Andreu, González-Pérez et al., 2012). EGFR-mediated relocalisation of nuclear CIC 
therefore contributes to defining the pipe expression border position by affecting the spatial 
distribution of Mirror in follicle cells. Loss of maternal CIC function therefore leads to dorsalisation 
of the embryo due to absence of pipe expression (Andreu, Ajuria et al., 2012).  
Increasing evidence regarding the involvement of CIC in RTK signalling and the fact that CIC fits the 
MyoD model for a transcriptional repressor led to our hypothesis that FGF regulated gene 
transcription is mediated, at least in part, by CIC. FGF has been shown to be the sole activator of 
ERK signalling in early development in Xenopus tropicalis (Christen and Slack, 1999), so CIC was 
identified as a potential component of the FGF pathway downstream of ERK.  
1.6 Relief of Capicua transcriptional repression via interactions with dpERK 
Capicua exists in 2 main isoforms with different sizes and N-terminal regions. In Xenopus tropicalis, 
CIC-long (CIC-L) contains N-terminal exon 1 (2812bp), whereas CIC-short (CIC-S) contains exon 2 
(49bp) instead (King, 2019). The remaining CIC exons (3-22) are common to both isoforms in 
Xenopus tropicalis and Mus musculus (Figure 2A). Xenopus tropicalis and Mus musculus CIC proteins 
both contain 7 functional domains: N1, ATXN-1, 14-3-3. HMG-box, C2, NLS and C1 (Astigarraga et 
al., 2007). The N1 domain is only present in the CIC-L isoform and not the shorter CIC-S protein 
(Figure 2B).  
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Figure 2: Schematic diagram of CIC exon structure and functional domains. A Capicua (CIC) 
consists of 22 exons. Exon 1 is specific to the CIC-long (CIC-L) isoform and exon 2 to the CIC-short 
(CIC-S) isoform. Both CIC-L and CIC-S share the common exons 3-22. B The CIC protein contains 7 
functional domains, 6 of which are found in both the CIC-L and CIC-S isoforms. The N1 domain is 
only present in the CIC-L protein 2. The HMG domain is a high mobility group-box domain and the 
NLS encodes a nuclear localisation sequence. 
Activated ERK acts via several mechanisms involving different functional domains to reduce nuclear 
levels or activity of CIC. For example, in Drosophila, dpERK binds to the C2 docking motif and directly 
phosphorylates CIC to induce degradation of the protein (Jimenez et al., 2012). dpERK binding of 
the C2 domain in fly and human model systems also mediates further phosphorylation of CIC in 
response to signalling. CICΔC2 mutant flies lacking the C2 domain exhibit a similar phenotype to 
Torso KO (Astigarraga et al., 2007). Without a functional C2 motif, CIC is insensitive to relief of 
repression by Torso signalling. This suggests that the C2 domain is essential for relief of CIC 
repression. 
CIC binds DNA via its High Mobility Group-box (HMG-box) domain, which recognises octameric 
T(G/C)AATG(A/G)A sites in target gene enhancers and promoters (Jimenez et al., 2012). The 14-3-3 
domain contains a serine or threonine residue which, once phosphorylated, recruits members of 
the 14-3-3 phosphoserine family of binding proteins. In human HEK-293 cell studies, ERK signal 
transduction activates p90 ribosomal S6 kinase (p90RSK) expression. p90RSK phosphorylates the 
serine at the 14-3-3 motif to create a docking site for 14-3-3 regulatory proteins (Dissanayake et al. 
2011). This blocks or reduces optimal binding efficiency of the neighbouring HMG-box domain to 
DNA leading to relief of repression by CIC.  
Human CIC contains a common nuclear localisation sequence (NLS) at the C-terminal. This allows 
binding of Importin α4 (KPNA3) leading to import of CIC into the nucleus. Activated ERK 
phosphorylates the NLS site at Ser1382 and Ser1409 and/or KPNA3 to prevent binding of KPNA3 to CIC 
and subsequent nuclear import (Astigarraga et al., 2007). 
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1.7 ERK signalling and the wound response 
ERK is also activated in response to injury. It has been demonstrated that 2 minutes after 
mechanical wounding of intestinal epithelial cell (IEC-6) monolayers, cells at the wound edge 
strongly express cytoplasmic dpERK. ERK signalling cascades then lead to further phosphorylation 
and transcription of genes needed for tissue repair such as early growth response-1 (Egr-1) and c-
Fos, peaking at 20 minutes post-wounding (Dieckgraefe et al., 1997). Active ERK1/2 expression is 
also upregulated in tissue repair following wounding of lens epithelial cell (LEC) monolayers (Wang 
et al., 2003). Additionally, healing is inhibited in LEC monolayer wounds treated with U0126, a 
specific inhibitor of ERK1/2 activation, thus indicating that ERK activity is required for the wound 
response.  
Pre-metamorphic Xenopus are able to heal epidermal wounds without scarring, as well as 
regenerate limbs, tails and lens’ as required (Beck et al., 2009). This makes them an excellent model 
for the investigation of wound healing and regenerative mechanisms. ERK is activated rapidly and 
transiently in response to wounding or dissection of a Xenopus embryo (Christen and Slack, 1999; 
LaBonne and Whitman, 1997). Xenopus embryonic wound healing has 2 phases (Li et al., 2013). The 
first of which involves activated ERK suppressing PI3 kinase activity to allow the subsequent 
activation of Rho and myosin-2. This leads to assembly of a contractile actomyosin cable in epithelial 
cells surrounding the wound (Martin and Lewis, 1992). This cable, along with the contraction and 
ingression of exposed deep mesenchymal cells, draws the wound together like a ‘purse string’ 
(Bement et al., 1999). Actomyosin cables have also been observed in the healing of adult tissues 
such as the intestinal and cornea epithelia so this mechanism may not be restricted only to the 
embryonic wound response (Bement et al., 1993; Danjo and Gipson, 1998). ERK signalling decreases 
after phase 1 to allow PI3 kinase signalling to resume, thus leading to increased Rac and Cdc42 
activity (Li et al., 2013). This allows filopodia formation at the wound leading edge to promote 
migration and wound closure. Unlike endogenous activation of ERK in Xenopus embryos, ERK 
activation in the wound response occurs independently of FGF and is unaffected by the presence 
of dominant negative FGF receptors (Christen and Slack, 1999). 
Activation of ERK has been shown to relieve transcriptional repression by CIC in several signalling 
pathways (Jimenez et al., 2012). As ERK is also involved in the wound response, this may be another 
mechanism through which target gene expression is regulated by ERK and CIC. We hypothesise that 
CIC functions in transcriptional regulation of genes involved in the wound response, in addition to 
FGF pathway target genes (Figure 3). 
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Figure 3: Hypothesised model for transcriptional regulation of FGF and wound response activated 
target genes. ERK (extracellular signal-regulated kinase) is phosphorylated when an injury is 
sustained or the FGF signalling pathway is activated. Phosphorylation of transcriptional repressor 
protein Capicua by diphosphorylated ERK leads to degradation or relocalisation of Capicua to the 
cytoplasm, thus allowing transcription of target genes. 
1.8 Capicua expression in Xenopus development 
CIC-L is maternally expressed at the 8-cell stage (stage 4) with enriched expression in the animal 
pole (Figure 4). CIC-S expression is initially lower but increases following the midblastula transition 
when zygotic gene transcription is activated. Both CIC isoforms are expressed in the marginal zone, 
at the dorsal blastopore lip, during early gastrulation (stage 10) (King, 2019). FGF3 and FGF8 are 
first expressed in early gastrula stage Xenopus around the blastopore in order to induce mesoderm 
in this CIC-expressing region (Lombardo et al., 1998; Christen and Slack, 1997).  As development 
continues, expression of CIC-L and CIC-S becomes more widespread and is particularly enriched in 
the otic vesicles, branchial arches, neural tube, notochord, somites, forebrain, midbrain and 
hindbrain (King, 2019), all known regions of FGF signalling (Lea et al., 2009). Widespread CIC 
expression would be necessary at early tailbud stage (stage 25) to prevent non-specific transcription 
of FGF dependent genes if CIC is the downstream repressor in this signalling pathway.  
 
Figure 4: The spatial expression pattern of CIC-L and CIC-S in Xenopus tropicalis analysed using in 
situ hybridisation (King, 2019). 8-cell stage 4 (animal view), early gastrula stage 10 (vegetal view) 
and early tailbud stage 25 (lateral view). Both Capicua isoforms (CIC-long and CIC-short) are 
enriched at the dorsal blastopore lip (dbl) during gastrulation and later in the otic vesicles (ov), 
branchial arches (ba) and neural tube (nt). Embryos staged according to Nieuwkoop and Faber 
(1994) stages of Xenopus development.  
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1.9 Project aims 
Although lots is known about the FGF transcriptome, the specific mechanism responsible for 
regulation of target gene transcription is still not fully understood. Evidence suggesting involvement 
of a labile transcriptional repressor (Fisher et al., 2002) led to identification of CIC as a strong 
candidate for this role, as the protein has been shown to function as a transcriptional repressor 
relieved by RTK signalling via ERK activation in multiple species (Jimenez et al., 2012). CIC is 
expressed in known regions of FGF activity, where activation of ERK in FGF signal transduction may 
lead to relief of target gene repression by CIC (King, 2019). ERK signalling cascades also mediate 
wound signal transduction and transcription of genes relevant to wound repair (Christen and Slack, 
1999; Li et al., 2013). Consequently, CIC may also regulate transcription of genes involved in the 
wound response independently of FGF. 
Hypothesis: Transcription of a subset of FGF target genes, and genes involved in the wound 
response, rely on ERK mediated relief of CIC transcriptional repression. 
The overall aims of this project are: 
 To establish if CIC operates downstream of FGF signalling through analysis and validation 
of RNA-seq data 
 To investigate the relationship between CIC and ERK in FGF signalling and embryonic wound 
healing 
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Chapter 2: Materials and methods 
2.1 Embryological methods 
2.1.1 Xenopus embryo culture 
Fertilised Xenopus tropicalis embryos were cultured in 1/9 strength Modified Ringers Solution 
(MRS)/9 (11.11mM NaCl. 0.2mM KCl, 0.22mM CaCl2, 0.11mM MgCl2, 5mM HEPES/NaOH (Tindall et 
al. 2007)) and staged according to Nieuwkoop and Faber (1994). Embryos were transferred to 
MRS/20 (5mM NaCl, 0.09mM KCl, 0.1mM CaCl2, 0.05mM MgCl2, 5mM HEPES) before gastrulation. 
Fertilised Xenopus laevis embryos were cultured in 1/3 strength Normal Amphibian Medium 
(NAM)/3 (3.7mM NaCl, 0.067mM KCl, 0.033mM Ca(NO3)2, 0.33mM MgSO4, 3.3µM EDTA, 5mM 
HEPES pH7.4, 1mM NAHCO3 (Slack and Forman, 1980)) and staged according to Nieuwkoop and 
Faber (1994). Embryos were transferred to NAM/10 (1.1mM NaCl, 0.02mM KCl, 0.01mM Ca(NO3)2, 
0.01mM MgSO4, 1µM EDTA, 5mM HEPES pH 7.4 (Slack and Forman, 1980)) before gastrulation. 
2.1.2 Microinjection 
Xenopus tropicalis injections were carried out in MRS/9 + 3% ficoll using the gas PM 1000 Cell 
Microinjector with pulled needles (Narishige). Xenopus laevis injections were carried out in NAM/3 
+ 5% ficoll using the Drummond Microinjector with pulled needles (Drummond). Injected embryos 
were cultured in the ficoll solutions to allow healing before transfer to MRS/20 and NAM/10 
respectively. Embryos were flash frozen on dry ice for RNA extraction and reverse transcription 
polymerase chain reaction (RT-PCR) or western blots, or fixed in MEMFA (0.1M MOPS pH 7.4, 2mM 
EGTA, 1mM MgSO4, 3.7% formaldehyde (Guille, 1999)) for in situ hybridisation (after removal of 
the vitelline membrane) or immunostaining. 
2.1.3 Wounding 
The vitelline membranes of late neurula stage 20 Xenopus laevis embryos were removed before 
creating a wound on one side of each embryo using a tungsten needle. Embryos were cultured in 
NAM/10 at 21°C and fixed at a range of time points post-wounding. 
The vitelline membranes of myc-CIC microinjected gastrula stage 10.5 Xenopus laevis embryos were 
removed from the vegetal pole to avoid unintentional damage to the animal pole. Embryos were 
then wounded at the microinjection site on the animal pole using a tungsten needle. The embryos 
were cultured in NAM/10 at 21°C for 30 minutes post-wounding before being fixed in MEMFA. 
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2.1.4 Photography  
Images of embryos were taken using the SPOT 14.2 Colour Mosaic camera (Diagnostic Instruments 
Inc.) and SPOT Advanced software with a Leica MZ FLIII microscope. Adobe Photoshop CS3 was 
used to process images.  
2.2 Molecular biology methods 
2.2.1 Extraction of total RNA 
In order to extract RNA, frozen Xenopus tropicalis embryos were homogenised in 1ml Tri-Reagent 
(Sigma-Aldrich) and left on ice for 1 minute. Samples were centrifuged at 13,000rpm for 10 minutes 
at 4°C and the supernatant placed at room temperature for 5 minutes. 200µl chloroform was added 
to the supernatant and left at room temperature for 5 minutes before being centrifuged at 
13,000rpm for 15 minutes at 4°C.  The aqueous phase was transferred to a new Eppendorf and 
200µl chloroform added before being centrifuged at 13,000rpm for 5 minutes at 4°C. 500µl 
isopropanol was added to the aqueous phase, vortexed and placed at -20°C for 29 minutes. Samples 
were centrifuged at 13,000rpm for 15 minutes at 4°C and the supernatant discarded. 200µl ice cold 
70% ethanol was added to the RNA pellet, vortexed and centrifuged at 13,000rpm for 10 minutes 
at 4°C. The supernatant was discarded and the pellet dried by desiccation. RNA was resuspended 
in 50µl 2.5M LiCl and placed at -20°C overnight to precipitate. Samples were then centrifuged at 
13,000rpm for 20 minutes at 4°C. 200µl ice cold 70% ethanol was added to the RNA pellet, vortexed 
and centrifuged at 13,000rpm for 5 minutes at 4°C. The pellet was dried by desiccation and 
resuspended in 20µl dH2O. 
2.2.2 cDNA synthesis 
cDNA was synthesised from 0.5μg RNA with 0.2µg random hexamers (Thermo Scientific) and 1µl 
10mM dNTP (Roche) made up to 13µl with dH2O. Reaction mixture was heated to 65°C for 5 
minutes then placed on ice for 1 minute before addition of 4µl 5x SSIV buffer (Invitrogen), 1µl 
100mM DTT (Invitrogen), 1µl 200U/µl SuperScript IV Reverse Transcriptase (Invitrogen) and 1µl 
dH2O. The mixture was then incubated at 23°C for 10 minutes, 55°C for 10 minutes and then 80°C 
for 10 minutes. 
IDT PrimerQuest (https://eu.idtdna.com/primerquest/home/index) was used to design gene 
specific primers with forward and reverse primers in different exons with amplicon sizes between 
400bp and 800bp (Table 2). 
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Gene Forward primer sequence 5’-3’ Reverse primer sequence 5’-3’ 
fos CCAGATCTTCAGTGGCTTGT CTATACAGTGGCTCCCATTCTG 
fosl1 TCGCAAGGAGCTAACAGATTAC CATGGACTTTGCTCTCCACTAC 
frzb GGCTGGTGCTCCTATCATTAC CCTTCATGGGCTTGCATTTAC 
rasl11b ATCTTGCCATCCAGGTTCAG CCTGCATGTTTGGTGACTTTG 
Table 2: Forward and reverse gene specific primer sequences for amplification of fos, fosl1, frzb 
and rasl11b. 
12.5µl PCR Master Mix 100rxn (Promega), 1.5µl 100µM forward and 1.5µl 100µM reverse gene 
specific primers and 7.5µl dH2O were used to amplify 2µl cDNA via PCR. The reaction mixture was 
heated to 95°C for 2 minutes before 30 cycles of 95°C for 30 seconds, 58°C for 50 seconds and 72°C 
for 30 seconds before a final elongation at 72°C for 10 minutes.  
PCR products were purified using the Quick-Start MinElute PCR Purification Kit (Qiagen) as per 
manufacturer’s protocol. 
2.2.3 Agarose gel electrophoresis 
DNA and RNA samples were separated on 1.5% agarose gels in Tris-Acetate-EDTA buffer (40mM 
Tris pH7.6, 20mM acetic acid, 1mM EDTA) stained with ethidium bromide. The 1kb plus DNA ladder 
(New England BioLabs) was run alongside to predict product sizes.  
2.2.4 Cloning of in situ hybridisation probe template 
PCR products were ligated into the pGEM-T Easy vector and transformed into E. coli competent 
cells (DH5α, Invitrogen). Transformations were grown overnight at 37°C on LB agar plates 
containing 100μg/ml ampicillin. 5-10 colonies were selected from each bacterial plate and each 
subjected to PCR with gene specific primers (Table 2) to determine which colonies had taken up the 
insert successfully. For each gene, 3 colonies that had successfully taken up the insert were selected 
and cultured overnight in 3ml LB-broth containing 100μg/ml ampicillin, in a shaker at 37°C, 250rpm. 
Plasmids were isolated from the bacterial cultures using the QIAprep Spin Miniprep Kit as per 
manufacturer’s protocol. DNA concentration was determined using the Nanodrop-8000 and an 
EcoR1 digest was carried out to confirm presence of the insert in the purified plasmids. Samples of 
the undigested plasmids were sequenced using the Eurofins Genomics postal sequencing service. 
Sequencing was analysed using SeqMan software from the Lasergene Genomics Suite (DNA Star) 
to confirm that the correct region had been amplified and identify in which orientation the insert 
had been incorporated into the plasmid. This determined which restriction enzyme and polymerase 
was used for each gene to produce antisense RNA probes.  
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2.2.5 In situ hybridisation probe synthesis 
1µg of plasmid DNA was linearised by 2µl of the appropriate enzyme (Table 3) with 10µl buffer and 
85µl dH2O at 37°C for 1.5-2 hours. 
Table 3: Enzymes, buffers and polymerases used for in situ hybridisation probe synthesis.  
Enzymes and buffers used to linearise fos, fosl1, frzb and rasl11b cDNA ligated into pGEM-T Easy 
plasmids. Polymerases used to generate RNA probes following linear plasmid purification. 
Linear plasmids were made up to 400µl with dH2O and 400µl phenol chloroform added. Samples 
were vortexed for 15 seconds then centrifuged at 13,000rpm for 5 minutes. The aqueous phase 
was transferred to a new Eppendorf and an equal volume of chloroform added. Samples were 
vortexed for 15 seconds, centrifuged at 13,000rpm for 5 minutes and the aqueous phase 
transferred to a new tube. DNA was precipitated with 30µl 3M sodium acetate, 600µl ethanol and 
1µl GlycoBlue (Invitrogen) at -20°C overnight. Samples were centrifuged at 13,000rpm for 20 
minutes at 4°C. 200µl ice cold 70% ethanol was added to the pellet before being vortexed and 
centrifuged at 13,000rpm for 5 minutes at 4°C. The pellet was dried by desiccation and resuspended 
in 23µl dH2O. 
Digoxigenin (DIG) labelled antisense RNA probes for in situ hybridisation (Table 4) were synthesised 
using 4µl 5x transcription buffer (NEB), 2µl 10x DIG NTP mix (Roche), 2µl 100mM DTT (Invitrogen), 
1µl polymerase (Ambion), 3µl DNA, 7µl dH2O at 37°C overnight. Plasmid DNA was degraded by 
incubating the reaction mixture with 1µl RNase-free DNase I (Promega) at 30°C for 20 minutes. 
Probes were precipitated overnight at -20°C with 50µl 5M ammonium acetate, 300µl ethanol, 50µl 
dH2O and 1µl GlycoBlue (Invitrogen). Samples were centrifuged at 13,000rpm for 15 minutes at 4°C. 
100µl ice cold 70% ethanol was added to the pellet before being vortexed and centrifuged at 
13,000rpm for 5 minutes at 4°C. The pellet was dried by desiccation and resuspended in 50µl dH2O. 
Plasmid Linearisation enzyme Buffer Polymerase 
pGEM-T Easy fos Nco1 H SP6  
pGEM-T Easy fosl1 Sal1 H T7  
pGEM-T Easy frzb Apa1 A SP6  
pGEM-T Easy rasl11b Nco1 H SP6  
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Table 4: Digoxigenin labelled antisense RNA probe sequences for in situ hybridisation of fos, fosl1, 
frzb and rasl11b. 
2.2.6 In situ hybridisation 
For in situ hybridisation (Harland, 1991), MEMFA fixed de-membraned embryos stored in ethanol 
at -20°C were rehydrated through a graded series of ethanols and washed in PBS with 0.1% Tween 
(PBSAT). Embryos were then treated with 10μg/ml proteinase K at room temperature for 2-13 
minutes depending on stage of development. They were then washed for 5 minutes in 0.1M 
triethanolamine pH 7.8 twice before two additions of 12.5µl acetic anhydride. Embryos were 
washed in PBSAT, re-fixed in 10% formaldehyde in PBSAT for 20 minutes, and washed in PBSAT 
again. Incubation in pre-hybridisation buffer (50% formamide, 5x SSC pH7, 100µg/ml heparin, 1x 
Denhart’s, 0.1% Tween, 0.1% CHAPS, 10mM EDTA) at 60°C on a horizontal tube rocker for 2 hours 
was carried out before hybridisation with 3µl/ml DIG labelled antisense RNA probes at 60°C 
overnight. Embryos were kept above 60°C and washed in hybridisation buffer twice for 10 minutes, 
2x SSC + 0.1% Tween three times for 20 minutes and 0.2x SSC + 0.1% Tween three times for 30 
minutes. Two 15 minute MABT (100mM maleic acid, 150mM NaCl, pH 7.8, 0.1% Tween) washes 
were then carried out at room temperature. Embryos were pre-incubated in 1ml MAB + 2% BMB + 
20% heat treated lamb serum at 60°C on a horizontal tube rocker for 2 hours. The solution was 
Gene Probe sequence
bmp7.2
CTTATCGGCGCTCAGTAGATGCTTGCACTGAGGACAGAACATTATTCTGCAACTGTTTTGCTGCACATGGACAGGAGCCTCCATC
CTTTTTGGAAAGAAGACTTCAATTTGTAAACCTTCCTCATACTCCATGCCTTCAAATTGCATAAACATGTTATATTAACTTTATATTGA
AAAAAAAACATCCACTATTTTATCTAAGTGGTTTGTAAACTCAAGGGATCTGGACGTAACATGAATCAAATGTTTCTGTTTGGATTC
GGCAGCAGTCAAGATATCAAGGATTATCTGTATAATTATCTTTAGTGTTTCATCATCCCCCTGTGCTCGGAAAATATCTTTGACAAA
ATGAATGCTTTGATAGTAAAGAGAAGATTGCCAGTGCTGCTTTTTCTTTTTTACATTTCCCTGAGTTCCATCTCA
fos
CCAGATCTTCAGTGGCTTGTACAGCCAACCCTTATTTCTTCTGTAGCCCCATCACAGTCTCGGGCACACCCTTATGGGTCCACACC
AGCTTACAGCCGATCTAGCGTTATGAAAGGATCTGCTGGAAGAGGTCAGAGCCTGGGAAGAAGAGGAAAAATGGAGCAGCTTT
CTCCagaagaagaagaaaaaaggaaagtaagacgagaaaggaataagaTGGCAGCTGCCAAGTGTCGTAACCGCCGTCGGGAGTTAA
CAGACACCCTTCAAGCGGAGACTGATGACCTGGAGGACCAGAAATCTGCCCTGCAGGCAGAGATTGCCGGCCTTCTAAAGGAG
AAGGAAAAGCTGGAGTTTATACTTGCAGCTCACAAACCAGCTTGCAAAATTCCACATGATCTTGATGGAGCTTTTCAAGACTTGAC
CTCATCTCTTGATCTGGGTCTGATTTCAGAGACCCCTTGTTCTTCCAGCTCTCAGGAGCCTGTAGCAGAGCCTCTGTTTCCCATTG
GCCTTTCTCAGTCTTCCATGCCTGAAAAGGAGAACACCCACTGCAAGTCTCTATGGAACTCAAATCTGAACCACTGGATGATTTTC
TGTTTAACTCTTCTCACACAGGTGTAACTGATGCAGCACGTTCTGTGCCAGATGTAGATCTTACTAGCTCTCTTTACACATCAGAAT
GGGAGCCACTGTATAG
fosl1
TCGCAAGGAGCTAACAGATTACCTGCAGGCAGAGACAGACAAACTTGAAGAAGAGAAGTCATCCCTCCAGAAAGAAATTGCTGA
GCTGCAGAAGCAGAAGGATAAGCTGGAACTCATCCTTGAGGCTCACCAGCCTATATGCAAGTTTCCTGACTCCCATCACAACATG
CAGCAAGTGGACTCCTCCAGGCTGGTTAAGAAGGAACCACATGAAGAGTCACCCAGGGGACCTAAAGTCAACCTTCCCAGGATA
GAGCTGAGCGACACAATCCTAGAGCCAGAGGCCCTTCACACCCCAACACTCATGAAGACACCATCCATTACTCCTTTTACGCCAA
ATTTGATATTCACTTATCCTGGTCCACAAGAATCATGTTCTACAGCGCACCGAAGGCTGAGCAGAAGCAGCAGCAGTGGTAGTAG
TGGAGAGCAAAGTCCATG
frzb
GGCTGGTGCTCCTATCATTACCCAACGCTCACTGTGCTTCATGTGAGCCTGTGCGGATTCCCATGTGCAAATCTATGCCATGGAAC
ATGACTAAAATGCCCAACCATCTCCACCACAGCACTCAAGCCAATGCCATTTTGGCAATTGAACAGTTTGAAGGTTTGCTGACCAC
TGAATGTAGCCAGGACCTTCTGTTCTTTCTGTGTGCTATGTATGCCCCCATTTGTACCATCGATTTCCAGCACGAGCCAATTAAGCC
TTGCAAATCTGTATGTGAAAGGGCCAGGGCCGGCTGTGAGCCCATTCTCATCAAGTACCGGCACACTTGGCCAGAGAGCCTGGC
ATGTGAGGAGCTCCCCGTATATGACAGAGGAGTCTGCATCTCCCCAGAGGCTATCATCACGGTGGAACAAGGAACAGATTCGAT
GCCAGACTTCCCCATGGATTCAAACAACGGAAATTGTGGAAGCACGGCAGGGGAGCACTGTAAATGCAAGCCCATGAAGG
rasl11b
ATCTTGCCATCCAGGTTCAGGACACACCAGGAGTACAGATAAATGATCAGAATCTGGACTCTAATGAGCAGCTCAACAAATCCCT
GAGATGGGCCGATGCTGTTGTGATCGTGTTCTCCATCACAGACTGTAAAAGCTTTGATCTTATCAGTCGCCTGCACCAGCACGCC
CGGCAGCTTCACCCCGATAACAGAATCCCTATTGTCATTGTCGCCAATAAAGCAGATCTGCTGCACCTGAAACAGGTGGAACCAC
AGCATGGACTTCAGCTGGCCAACATGTTGGGTTGCACTTTCTATGAAGTGAGTGTTAGCGAGAACTATATCGATGTGTACAATGC
TTTCCAGGTACTGTGTAAAGAAATCAGCAAGCAGCAGAACACAGGAACCCCTGAAAGGCGGAAAAACTCGCTTATTCCACGTCCA
AAGTCACCAAACATGCAGGA
Gene Probe sequence
bmp7.2
TTATCGGCGCTCA TAGA G TTG CTGAGGACAGAACAT TT TGCAACTGT TTGCTGCACATGGAC G A C TC T
CTTTTTGGAAAGAAGACTTCAATTTGT ACC TCCTCATACTCCATG CTTCAAATT C TA CATGTT T TTAACTTT TATTGA
AAAAAAAACATCCACTATTTTATCTAAGTGGTTTGTAAACTCAAGGGAT TGGACGT CATGAATCAAATGTTTCT TTTG ATTC
GGC GCAGTCAAGATATC AGGATTATCTG ATA TT TCTTT GTGT T ATCATCCCC T T C C GAAAATA TTGACAAA
T A TGCTTTGAT AA GAGAAG TTG CAGTG TGCT TT TTTT A TTTCCC GA TTCCATCTCA
fos
CCAGATCTTCAGTGGCTTGTACAGCCAACCCTTATTTCTTCTGTAGCCCCATCACAGTCTCGGGCACACCCTTATGGGTCCACACC
AGCTTACAGCCGATCTAGCGTTATGAAAGGATCTGCTGGAAGAGGTCAGAGCCTGGGAAGAAGAGGAAAAATGGAGCAGCTTT
CTCCagaagaagaagaaaaaaggaaagtaagacgagaaaggaataagaTGGCAGCTGCCAAGTGTCGTAACCGCCGTCGGGAGTTAA
CAGACACCCTTCAAGCGGAGACTGATGACCTGGAGGACCAGAAATCTGCCCTGCAGGCAGAGATTGCCGGCCTTCTAAAGGAG
AAGGAAAAGCTGGAGTTTATACTTGCAGCTCACAAACCAGCTTGCAAAATTCCACATGATCTTGATGGAGCTTTTCAAGACTTGAC
CTCATCTCTTGATCTGGGTCTGATTTCAGAGACCCCTTGTTCTTCCAGCTCTCAGGAGCCTGTAGCAGAGCCTCTGTTTCCCATTG
GCCTTTCTCAGTCTTCCATGCCTGAAAAGGAGAACACCCACTGCAAGTCTCTATGGAACTCAAATCTGAACCACTGGATGATTTTC
TGTTTAACTCTTCTCACACAGGTGTAACTGATGCAGCACGTTCTGTGCCAGATGTAGATCTTACTAGCTCTCTTTACACATCAGAAT
GGGAGCCACTGTATAG
fosl1
TCGCAAGGAGCTAACAGATTACCTGCAGGCAGAGACAGACAAACTTGAAGAAGAGAAGTCATCCCTCCAGAAAGAAATTGCTGA
GCTGCAGAAGCAGAAGGATAAGCTGGAACTCATCCTTGAGGCTCACCAGCCTATATGCAAGTTTCCTGACTCCCATCACAACATG
CAGCAAGTGGACTCCTCCAGGCTGGTTAAGAAGGAACCACATGAAGAGTCACCCAGGGGACCTAAAGTCAACCTTCCCAGGATA
GAGCTGAGCGACACAATCCTAGAGCCAGAGGCCCTTCACACCCCAACACTCATGAAGACACCATCCATTACTCCTTTTACGCCAA
ATTTGATATTCACTTATCCTGGTCCACAAGAATCATGTTCTACAGCGCACCGAAGGCTGAGCAGAAGCAGCAGCAGTGGTAGTAG
TGGAGAGCAAAGTCCATG
frzb
GGCTGGTGCTCCTATCATTACCCAACGCTCACTGTGCTTCATGTGAGCCTGTGCGGATTCCCATGTGCAAATCTATGCCATGGAAC
ATGACTAAAATGCCCAACCATCTCCACCACAGCACTCAAGCCAATGCCATTTTGGCAATTGAACAGTTTGAAGGTTTGCTGACCAC
TGAATGTAGCCAGGACCTTCTGTTCTTTCTGTGTGCTATGTATGCCCCCATTTGTACCATCGATTTCCAGCACGAGCCAATTAAGCC
TTGCAAATCTGTATGTGAAAGGGCCAGGGCCGGCTGTGAGCCCATTCTCATCAAGTACCGGCACACTTGGCCAGAGAGCCTGGC
ATGTGAGGAGCTCCCCGTATATGACAGAGGAGTCTGCATCTCCCCAGAGGCTATCATCACGGTGGAACAAGGAACAGATTCGAT
GCCAGACTTCCCCATGGATTCAAACAACGGAAATTGTGGAAGCACGGCAGGGGAGCACTGTAAATGCAAGCCCATGAAGG
rasl11b
ATCTTGCCATCCAGGTTCAGGACACACCAGGAGTACAGATAAATGATCAGAATCTGGACTCTAATGAGCAGCTCAACAAATCCCT
GAGATGGGCCGATGCTGTTGTGATCGTGTTCTCCATCACAGACTGTAAAAGCTTTGATCTTATCAGTCGCCTGCACCAGCACGCC
CGGCAGCTTCACCCCGATAACAGAATCCCTATTGTCATTGTCGCCAATAAAGCAGATCTGCTGCACCTGAAACAGGTGGAACCAC
AGCATGGACTTCAGCTGGCCAACATGTTGGGTTGCACTTTCTATGAAGTGAGTGTTAGCGAGAACTATATCGATGTGTACAATGC
TTTCCAGGTACTGTGTAAAGAAATCAGCAAGCAGCAGAACACAGGAACCCCTGAAAGGCGGAAAAACTCGCTTATTCCACGTCCA
AAGTCACCAAACATGCAGGA
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replaced with fresh solution with the addition of a 1/2,000 dilution of anti-DIG antibody coupled to 
alkaline phosphatase (Roche) and rolled at 4°C overnight. Embryos were washed in MABT before a 
3 minute and 10 minute wash in alkaline phosphatase buffer (100mM Tris pH 9.5, 50mM MgCl2, 
100mM NaCl, 0.1% Tween). Staining was visualised by addition of BM purple (Roche). Embryos were 
bleached in 5% H2O2 in PBSAT to aid gene expression pattern visualisation.  
2.2.7 Immunostaining 
For immunostaining (Christen and Slack, 1999), MEMFA fixed embryos stored in ethanol at -20°C 
were rehydrated through a graded series of ethanols and washed in PBS. Embryos were then 
treated with K2Cr2O7 in 5% acetic acid at room temperature for 40 minutes. They were then washed 
in PBS before being bleached for 45 minutes in 5% H2O2 in PBS and washed in PBS again. Embryos 
were blocked in BBT (PBS, 1% BSA, 0.1% Triton X-100) + 5% horse serum for 1 hour before 
incubation in a 1/10,000 dilution of dpERK1+2 monoclonal mouse antibody (Sigma) or 1/5,000 
dilution of αmyc 9E-10a monoclonal mouse antibody (Cell Signaling Technology) at 4°C overnight. 
Embryos were washed in BBT then BBT + 5% horse serum for 1 hour before incubation with BBT + 
5% horse serum with a 1/1000 dilution of horse anti-mouse igG-AP conjugated secondary 
(VectorLab) overnight at 4°C. Immunostaining was visualised by addition of BM purple (Roche). If 
necessary, embryos were bleached in 5% H2O2 in PBS again to better visualise staining.  
2.2.8 Western blots 
Five Xenopus laevis embryos collected at gastrula stage 10.5, flash frozen and stored at -80°C were 
homogenised in 50µl Phosphosafe buffer (Novagen) and centrifuged at 13,000 rpm for 1 minute. 
The supernatant was added to 50µl of sample buffer (120mM Tris/Cl pH6.8, 20% glycerol, 4% SDS, 
0.04% bromophenol blue, 10% β-mercaptoethanol) and heated at 90°C for 5 minutes. 20µl of 
sample was loaded per lane of 10% SDS-PAGE gel in addition to 10µl PageRuler prestained protein 
ladder (ThermoScientific) and run at 180V for 2 hours. Proteins were transferred to Immobilon-P 
Transfer Membrane (Millipore) by electroblotting wet transfer in 10% methanol transfer buffer at 
85V for 2 hours. Membranes were washed in PBSAT and blocked in PBSAT + 5% milk powder 
(blocking solution) for 1 hour at room temperature. Membranes were then transferred to fresh 
blocking solution containing primary antibodies (dpERK at a 1:4,000 dilution) and left overnight at 
4°C. Membranes were washed in PBSAT and blocked for 30 minutes at room temperature before 
transfer to blocking solution containing secondary antibody (anti-mouse diluted to 1:4,000) for 1 
hour at room temperature. After further PBSAT washes, BM Chemiluminescence Blotting Substrate 
kit (Roche) and ECL Hyperfilm (Amersham) were used to detect proteins. Membranes were stripped 
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twice for 5 minutes in stripping buffer (137mM NaCl, 20mM glycine, pH2.5) and re-probed for total 
ERK (1:500,000) with secondary anti-rabbit antibody (1:2,000). 
2.3 Data analysis 
2.3.1 Differential expression analysis of RNA-seq data 
Xenopus tropicalis mRNA samples of CIC knockdown by TALENs, water injected and FGF4 
overexpressing embryos were collected in triplicate by Michael King, a PhD student in the Isaacs’ 
lab (King, 2019). RNA was analysed using the bioanalyzer to confirm RNA quality. Library 
preparation and Illumina sequencing was carried out by Bioscience Technology Facility staff at the 
University of York. A single lane of the Illumina HiSeq 2000 platform was utilised for sequencing 
samples. First strand cDNA synthesis was carried out using random hexamers and reverse 
transcriptase to construct the cDNA library. Each cDNA was then sequenced in a high-throughput 
manner to obtain a read count. The number of reads found for each transcript was used to calculate 
transcripts per million (TPM). TPM is a measure of the abundance of each transcript in each sample 
adjusted to take into account the varying number of reads sequenced for each sample, and the 
varying expression of transcripts of the whole transcriptome. For example, the TPM value for 
‘transcript A’ should represent the number of transcripts of A that would be observed if one million 
transcripts were sequenced from the whole transcriptome.   
2.3.2 Gene ontology analysis of RNA-seq data 
Initial RNA-seq bioinformatics analysis was performed at the University of York Bioscience 
Technology Facility. Raw reads for each sample were aligned to the Xenopus tropicalis reference 
transcriptome (genome v9.1) (http://www.xenbase.org/common/displayJBrowse.do?data= 
data/xt9_1) using Salmon (http://salmon.readthedocs.io) to produce estimated read counts for 
each transcript for each sample. Sleuth (http://pachterlab.github.io/sleuth/) was then used to 
calculate differential expression (Q values and effect sizes) by fitting a statistical model to the 
estimated read counts.  
43,558 transcripts were found for 23,635 genes. Transcripts with a q value < 0.05 and effect size > 
1.5 in CIC knockdown and/or FGF4 overexpression were selected for gene ontology (GO) analysis 
using the Protein ANalysis THrough Evolutionary Relationships (PANTHER) classification tool (Mi et 
al., 2013) (http://www.pantherdb.org/). Genes were classified according to the PANTHER GO-Slim 
subset of GO terms. The PANTHER GO-Slims are GO terms identified by GO phylogenetic annotation 
and expert review as both informative of function and evolutionarily conserved (Mi et al., 2019). 
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2.3.3 Motif enrichment 
MEME suite 5.0.5 was used to determine whether CIC binding sites were enriched at the genomic 
locus of genes potentially regulated by CIC and FGF (http://meme-suite.org/tools/ame). Analysis of 
motif enrichment was carried out using Fisher’s exact test with the average odds score used for 
sequence scoring.  1004 control sequences were generated by randomly shuffling the input 
sequences conserving frequencies of word size 1. The E value threshold for reporting enriched 
motifs used was E ≤ 10. 
2.3.4 ImageJ analysis of myc immunostaining 
Stained areas of equal size for 5 embryos per treatment were converted to 16-bit grayscale and 
each image duplicated to create an identical copy. The threshold in the copy was adjusted to create 
a binary image with stained areas to be measured highlighted. Measurements were set to redirect 
to the un-thresholded version and highlighted particles of the binary image analysed.  
2.3.5 ImageJ analysis of western blots 
Western blot lanes were selected and profile plots of each generated using ImageJ. A straight line 
was drawn along the base of each peak to enclose the peak and exclude background noise. The 
area of each peak was then measured and the relative density calculated by dividing each by the 
corresponding loading control peak area and then normalised un-injected control peak area.  
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Chapter 3: Transcriptomic analysis of FGF4 overexpression and 
Capicua knockdown in Xenopus tropicalis  
 
3.1 Introduction 
As discussed in the introduction (Chapter 1), we hypothesise that transcription of a subset of FGF 
target genes relies on ERK mediated relief of CIC transcriptional repression. If CIC is responsible for 
repressing gene transcription in the absence of FGF signalling, disruption of the CIC gene should 
have a similar effect on the resulting transcriptome as an overexpression of FGF4. Consequently, 
an RNA-seq experiment was carried out by a PhD student in the Isaacs’ lab (King, 2019) in triplicate 
on control, FGF4 overexpressing, and CIC knockdown (via transcription activator-like effector 
nucleases (TALENs)) Xenopus tropicalis embryos.  
TALENs are composed of a non-specific DNA-cleaving nuclease (Fokl) fused to a TAL effector DNA-
binding domain capable of being engineered to target a specific sequence (Lei et al., 2012). A pair 
of forward and reverse TALENs sequences are used to bind effector binding element upstream and 
downstream of the target region. This can be utilised for genome editing by inducing double-strand 
breaks in target DNA sequences, which cells respond to with error-prone repair mechanisms such 
as non-homologous end joining (NHEJ) (Moore and Haber, 1996) leading to production of non-
functional gene products or nonsense mediated decay of the mRNA. In this case, TALENs were 
designed to target the HMG-box domain of CIC as this is the site responsible for binding octameric 
T(G/C)AATG(A/G)A sequences in target gene enhancers and promoters (Jimenez et al., 2012). 
Chromosomal rearrangement or introduction of nucleotide insertions or deletions following NHEJ 
in this region should result in any CIC protein produced being unable to function. In Xenopus, the 
HMG-box coding region spans exon 6 and 7. Consequently, the forward and reverse TALENs used 
were designed to flank and target exon 6 in order to induce double-strand breaks in this region. 
91.8% (74/81) of Xenopus tropicalis embryos injected with a total of 1ng forward and reverse 
TALENs mRNA exhibited a mutant phenotype ranging in severity from reduced head/eye 
pigmentation or cyclopia (50.8%) to total head loss (16.1%) (King, 2019). Most embryos also 
displayed an enlarged proctodaeum. Sequencing of DNA extracted from 8 of the TALENs injected 
embryos at late tailbud stage (40-41) revealed a 100% targeting efficiency with indels successfully 
introduced adjacent to the target site (King, 2019). The range of severity of phenotype is due to the 
mosaicism associated with TALENs targeting. The TALENs system requires production of the TALEN 
proteins from injected mRNA to target and knockdown CIC. Although the TALEN mRNAs are 
translated as soon as they are injected, the protein levels take a while to accumulate to the level 
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necessary for targeting to occur. As the protein is accumulating, cell division is already occurring so 
multiple independent targeting events may occur in different cells leading to a mosaicism of 
daughter cells within the embryo. Additionally, TALENs can disrupt both alleles of a gene leading to 
production of 2 different mutations following NHEJ in somatic cells. Indel mutations are usually 
located in the spacer region between the TALENs effector binding elements so the TALENs pair may 
bind again, thus introducing additional mutations during development (Lei et al., 2012).  
Until the midblastula transition (MBT), the zygotic genome is quiescent, and development is 
controlled by maternal factors within the cytoplasm (Lee et al., 2014). Consequently, there is no 
transcription of TALENs targeted loci until after the MBT, and any maternally deposited CIC mRNA 
is wild type. To ensure that very early development was not affected in either set of embryos, FGF4 
was injected into embryos in a CSKA plasmid construct with a β-actin promoter which does not 
become active until after the MBT (Isaacs et al., 1994). Embryos were collected at neurula stage 14 
for RNA-seq analysis using Illumina hi-seq. The abundance of 43,558 transcripts for 23,635 genes 
was analysed for 3 batches of FGF4 injected, CIC knockdown and water injected embryos.  
The aims of this chapter are: 
 Analyse RNA-seq data to identify genes upregulated and downregulated by FGF4 
overexpression and CIC inhibition 
 Undertake gene ontology enrichment analysis in order to identify biological processes 
associated with upregulated genes 
 Establish the statistical significance of the overlap in genes upregulated and downregulated 
by both FGF4 overexpression and CIC inhibition 
 Select putative FGF and CIC regulated target genes for validation of RNA-seq data 
 Determine if target genes are expressed in regions of CIC and FGF expression 
 Validate RNA-seq data using RT-PCR with primers specific to target genes 
 Analyse level of enrichment of CIC binding sites around the genomic loci of target genes 
3.2 Results 
3.2.1 Changes in gene expression as a result of CIC inhibition and FGF4 overexpression 
Initial quality control of the RNA-seq data and mapping of sequences to the Xenopus tropicalis 
transcriptome was undertaken by John Davey at the University of York Technology Facility. Data 
was then sorted to identify annotated transcripts with statistically significant changes in expression 
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by assessing calculated q value and effect size for each transcript. A q value is a measure of 
statistical significance of differential expression which allows for false positives. The smaller the 
value, the more significant the change in expression and the fewer genes expected to be false 
positives. Effect sizes are calculated by linear models representing the relative change in expression 
between treated and control samples. An effect size of 1 indicates no change in gene expression 
compared to the control group after any batch effects have been taken into account. An effect size 
greater than 1 indicates an upregulation of gene expression and an effect size less than 1 represents 
a downregulation of gene expression.  For example, an effect size of 2 represents a 2 times change 
in gene expression and an effect size of 0.5 indicates a 0.5 times change in gene expression. Gene 
transcripts with a q value < 0.05 and an effect size > 1.5 (for upregulated genes) or < 0.75 (for 
downregulated genes) were identified. Out of 43,558 transcripts, 331 and 81 fit these criteria for 
upregulated genes in CIC knockdown and FGF4 overexpressing embryos respectively (Table 5). 100 
transcripts had a q value > 0.05 and an effect size < 0.75 in CIC knockdown embryos and 92 in FGF4 
overexpressing embryos (Table 6). The complete gene transcript list from this RNA-seq experiment 
is available on Google Drive 
(https://drive.google.com/open?id=13gbNFwAbD00BSEWvahELt1lYPjyTGHv7). 
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Table 5: Gene transcripts upregulated in both CIC knockdown and FGF4 injected Xenopus 
tropicalis embryos.  Gene transcripts with an RNA-seq q value < 0.05 and effect size > 1.5 are 
classed as upregulated. Embryos collected at neurula stage 14 for RNA-seq analysis. 
 
 
Transcript ID Gene 
CIC knockdown FGF4 injection 
q value Effect size q value Effect size 
NM_001078836.1 apold1 0.004 4.69 0.002 5.45 
NM_001079231.1 arrdc2 5.75x10-7 2.56 3.10x10-6 2.47 
XM_012965809.2 arrdc2 2.17x10-4 2.05 2.50x10-6 2.44 
XM_002934698.4 atf3 3.91x10-4 1.96 0.014 1.76 
XM_018091031.1 b4galt1.1 0.030 2.21 0.018 2.44 
XM_012970501.2 bmp7.2 2.16x10-5 25.23 0.001 15.07 
XM_012964062.2 c4bpa 0.041 2.17 0.008 2.63 
NM_001102857.1 cbx4 0.028 2.22 0.001 2.87 
XM_004916833.3 chic1 0.003 1.83 0.041 1.67 
NM_203542.1 cldn6.1 0.003 1.85 0.015 1.78 
XM_002931681.4 exoc3l1 0.005 5.81 8.94x10-5 9.97 
XM_012952528.1 fam83c 0.007 1.89 0.001 2.12 
NM_001045662.1 fam83c 0.040 1.80 0.026 1.93 
XM_004911187.3 fat1 1.41x10-4 1.96 0.036 1.63 
XM_004914180.3 fgd3 0.024 20.40 0.045 20.21 
NM_001016200.2 fos 1.42x10-12 4.43 7.15x10-17 5.38 
XM_002939331.4 fosl1 0.005 3.09 0.015 3.00 
NM_001005438.1 frzb 0.001 4.49 0.045 3.21 
XM_012961068.2 gadd45a 0.003 1.58 0.027 1.51 
NM_001142145.1 gpcpd1 0.007 2.49 0.018 2.45 
XM_002936205.4 htr1b 5.14x10-6 24.11 0.027 7.75 
XM_004919807.3 ier3 4.83x10-5 2.63 0.001 2.33 
XM_002932276.4 LOC100485153 0.041 11.79 0.004 24.59 
XM_012962310.2 LOC100486038 0.019 2.24 0.003 2.66 
XR_001924462.1 LOC101730746 0.041 1.80 0.017 1.99 
XM_012953285.1 LOC101731310 7.19x10-5 28.53 0.025 11.53 
XM_004914317.3 LOC101732940 5.75x10-7 4.61 0.001 3.24 
XM_018090681.1 LOC101733948 0.008 2.22 0.001 2.68 
XM_018090141.1 LOC105945708 0.048 1.96 0.001 2.75 
XR_001170914.1 LOC105947461 0.001 2.11 7.13x10-5 2.44 
NM_001030330.1 mmp1 2.65x10-4 8.19 0.043 4.65 
XM_004915576.3 mst1 0.040 1.68 0.009 1.89 
NM_001130266.1 nfkbiz 0.006 2.13 0.027 2.02 
NM_001015693.1 pnpla3 0.002 1.64 0.008 1.60 
NM_001015774.1 rasl11b 3.45x10-7 2.60 0.001 1.99 
XM_018091191.1 sat1 0.032 1.73 0.017 1.86 
NM_001007996.1 sat1 1.44x10-4 1.64 0.001 1.59 
XM_012963073.2 sgk1 2.26x10-4 2.45 7.13x10-5 2.66 
NM_001030422.1 sgk1 0.002 2.04 1.86x10-5 2.51 
NM_001097368.1 sox17b.2 6.00x10-4 1.66 0.016 1.53 
XM_012960662.2 tmcc1 0.005319 14.59 0.032 11.36 
NM_001142914.1 tmcc1 0.014 1.59 0.018 1.62 
NM_001142050.1 usp2 1.74x10-5 3.48 0.045 2.22 
NM_001017208.2 wnt8a 0.041 1.83 0.004 2.20 
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Transcript ID Gene 
CIC knockdown FGF4 injection 
q value Effect size q value Effect size 
XM_018095307.1 atp2a2 0.047 0.741 0.006 0.680 
NM_001127035.1 axl 0.014 0.567 0.030 0.571 
NM_001006762.1 cebpa 0.017 0.363 0.001 0.277 
XM_012960859.1 celsr2 0.004 0.653 0.025 0.677 
NM_001011044.1 cygb 0.024 0.545 0.005 0.481 
NM_001126689.1 dpysl3 0.011 0.588 0.043 0.609 
NM_001006869.1 efnb3 0.011 0.682 0.017 0.678 
NM_001079128.1 irx3 1.71x10-5 0.599 0.042 0.717 
NM_001097188.1 LOC100485697 0.001 0.603 0.042 0.670 
XM_002934275.4 msi1 1.82x10-4 0.503 0.020 0.587 
XM_012961432.2 nkain1 0.027 0.554 0.041 0.545 
NM_001005637.1 notch3 6.86x10-5 0.617 0.023 0.701 
XM_004917080.2 pax6 0.018 0.316 0.009 0.273 
XM_002939393.4 pax6 0.033 0.300 0.030 0.274 
XM_002933915.4 ripply2.2 0.004 0.639 0.030 0.671 
XM_002932136.4 s1pr5 0.016 0.702 0.020 0.691 
NM_001113010.1 serpina1 0.016 0.670 0.030 0.668 
XR_001923782.1 slc23a2 0.011 0.586 2.41x10-5 0.459 
NM_001127068.1 spib 0.005 0.183 0.001 0.137 
XM_018092518.1 unc13d 2.98x10-4 0.205 0.013 0.269 
NM_001001216.1 znf219 0.001 0.493 0.045 0.583 
Table 6: Gene transcripts downregulated in both CIC knockdown and FGF4 injected Xenopus 
tropicalis embryos.  Gene transcripts with an RNA-seq q value < 0.05 and effect size < 0.75 are 
classed as downregulated. Embryos collected at neurula stage 14 for RNA-seq analysis. 
3.2.2 Gene ontology enrichment analysis to aid identification of potential CIC and FGF 
regulated target genes 
In order to investigate which biological processes genes upregulated in the RNA-seq data set are 
involved in, gene ontology (GO) enrichment analysis was carried out to allow classification of genes 
according to their functional characteristics. The PANTHER classification system (Mi et al., 2013) 
(www.pantherdb.org) was used to perform Fisher’s exact statistical overrepresentation tests and 
calculation of false discovery rate (FDR). This analysis was carried out on all genes identified as 
significantly upregulated in the FGF4 overexpressing (Table 7) and CIC knockdown embryos (Table 
8) respectively. Genes were classified according to the PANTHER GO-Slim biological process subset 
of GO terms which have been previously identified as both informative of function and 
evolutionarily conserved (Mi et al., 2019).  
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PANTHER GO-Slim 
Biological Process 
Number 
of genes 
Expected 
Fold 
enrichment 
+/- 
Raw P 
value 
FDR 
Transmembrane 
receptor protein 
tyrosine kinase 
signalling pathway 5 0.31 16.35 + 1.59x10-5 1.27x10-3 
ERK/MAPK cascade 8 0.81 9.9 + 1.49x10-6 1.79x10-4 
Intracellular signal 
transduction 13 2.6 4.99 + 1.28x10-6 3.06x10-4 
Developmental 
process 10 3.29 3.04 + 1.39x10-3 4.18x10-2 
Signal transduction 16 5.63 2.84 + 7.98x10-5 4.79x10-3 
Cell communication 16 6.42 2.49 + 3.70x10-4 1.48x10-2 
Cellular process 32 18.38 1.74 + 1.16x10-4 5.58x10-3 
Unclassified 13 25.69 0.51 - 3.76x10-4 1.29x10-2 
Table 7: Biological processes associated with gene transcripts upregulated in FGF4 overexpressing 
Xenopus tropicalis embryos.  Gene ontology processes identified using PANTHER Fisher’s exact 
statistical overrepresentation test with false discovery rate (FDR). GO-Slim biological processes are 
a subset of gene ontology terms identified by the PANTHER classification system indicating the 
biological systems to which a protein contributes.  
 
Figure 5: Bar chart showing fold enrichment for biological processes associated with gene 
transcripts upregulated in FGF4 overexpressing Xenopus tropicalis embryos.  Gene ontology 
processes identified using PANTHER Fisher’s exact statistical overrepresentation test with false 
discovery rate (FDR). GO-Slim biological processes are a subset of gene ontology terms identified 
by the PANTHER classification system indicating the biological systems to which a protein 
contributes. 
PANTHER GO analysis identified 7 biological processes associated with genes significantly 
upregulated in FGF4 overexpressing embryos (Figure 5). The GO terms with the highest fold 
enrichment were the transmembrane receptor protein tyrosine kinase signalling pathway, 
ERK/MAPK cascade, intracellular signal transduction and developmental process. This further 
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supports the hypothesis that these genes are regulated by FGF as FGF4 typically acts via tyrosine 
kinase receptors to activate ERK cascades intracellularly to regulate multiple developmental 
processes. 
PANTHER GO-Slim 
Biological Process 
Number 
of genes 
Expected 
Fold 
enrichment 
+/- 
Raw P 
value 
FDR 
Cell proliferation 8 0.66 12.21 + 6.39x10-7 1.53x10-4 
Regulation of cell 
cycle 11 2.22 4.95 + 2.18x10-5 1.31x10-3 
Mitosis 8 2.16 3.71 + 1.78x10-3 3.89x10-2 
Response to stress 17 5.00 3.40 + 1.69x10-5 1.35x10-3 
Response to external 
stimulus 9 2.77 3.25 + 2.24x10-3 4.48x10-2 
Cell death 10 3.39 2.95 + 2.62x10-3 4.50x10-2 
Death 10 3.39 2.95 + 2.62x10-3 4.84x10-2 
Cell adhesion 10 3.46 2.89 + 2.98x10-3 4.77x10-2 
Biological adhesion 10 3.46 2.89 + 2.98x10-3 4.48x10-2 
ERK/MAPK cascade 10 3.49 2.87 + 3.15x10-3 4.45x10-2 
Regulation of 
phosphate metabolic 
process 14 5.37 2.61 + 1.24x10-3 3.30x10-2 
Organelle 
organization 26 11.70 2.22 + 2.10x10-4 8.39x10-3 
Intracellular signal 
transduction 24 11.23 2.14 + 5.59x10-4 1.92x10-2 
Phosphate-
containing 
compound metabolic 
process 31 16.32 1.90 + 6.70x10-4 2.01x10-2 
Metabolic process 82 56.05 1.46 + 1.30x10-4 6.24x10-3 
Cellular process 112 79.28 1.41 + 7.87x10-6 9.45x10-4 
Unclassified 87 110.82 0.79 - 1.43x10-3 3.42x10-2 
Table 8: Biological processes associated with gene transcripts upregulated in CIC knockdown 
Xenopus tropicalis embryos.  Gene ontology processes identified using PANTHER Fisher’s exact 
statistical overrepresentation test with false discovery rate (FDR). GO-Slim biological processes are 
a subset of gene ontology terms identified by the PANTHER classification system indicating the 
biological systems to which a protein contributes. 
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Figure 6: Bar chart showing fold enrichment for biological processes associated with gene 
transcripts upregulated in CIC knockdown Xenopus tropicalis embryos. Gene ontology processes 
identified using PANTHER Fisher’s exact statistical overrepresentation test with false discovery rate 
(FDR). GO-Slim biological processes are a subset of gene ontology terms identified by the PANTHER 
classification system indicating the biological systems to which a protein contributes. 
PANTHER GO analysis identified 16 biological processes associated with genes significantly 
upregulated in CIC knockdown embryos (Figure 6). The GO term with the highest fold enrichment 
was cell proliferation. This is encouraging as FGF is important in regulation of cell proliferation. 
Other genes were involved in the same processes as those upregulated in the FGF overexpression 
such as ERK/MAPK cascade, intracellular signal transduction and cellular process.  
A strong overlap between significantly upregulated and downregulated gene transcripts was 
observed in CIC knockdown and FGF overexpressing embryos with 44 upregulated and 21 
downregulated in both (Figure 7). 
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Figure 7: Venn diagrams showing the overlap between significantly upregulated and 
downregulated gene transcripts in CIC knockdown and FGF4 overexpressing Xenopus tropicalis 
embryos.  (A) Upregulated genes: RNA-seq q value < 0.05 and effect size > 1.5 (B) Downregulated 
genes: RNA-seq q value < 0.05 and effect size < 0.75. Embryos collected at neurula stage 14. 
3.2.3 Establishing the statistical significance of observed gene overlaps 
In order to investigate the probability of the observed overlaps, Python was used to randomly 
sample sets of the number of upregulated genes (331 and 81) from numbers between 1 and 23,635 
(number of genes in the Xenopus tropicalis genome) and the size of the overlap between the 2 sets 
recorded (Figure 8a). The highest number of overlaps in 100,000 runs was 8 so the probability of 
getting an overlap of size 9 or greater is p < 0.00001. Consequently, an overlap of 44 upregulated 
genes is statistically significant. 
Sets of 100 and 92 numbers were randomly sampled for downregulated genes (Figure 8b). The 
highest number of overlaps in 100,000 runs was 5 so the probability of getting an overlap of size 6 
or greater is p < 0.00001. Consequently, an overlap of 21 significantly downregulated genes is 
statistically significant. 
 
 
A  Upregulated gene B  Downregulated genes 
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Figure 8: Histograms showing expected size of overlaps modelling RNA-seq data using Python.  
(A) Upregulated genes: 331 gene transcripts had an RNA-seq q value < 0.05 and an effect size > 1.5 
in Xenopus tropicalis embryos injected with FGF4, and 81 gene transcripts in CIC knockdown 
embryos with an overlap of 44. Histogram shows size of overlaps generated by random sampling of 
sets of 331 and 81 numbers between 1 and 23,635 (number of genes in the Xenopus tropicalis 
genome). (B) Downregulated genes: 100 gene transcripts had an RNA-seq q value < 0.05 and an 
effect size < 0.75 in Xenopus tropicalis embryos injected with FGF4, and 92 gene transcripts in CIC 
knockdown embryos with an overlap of 21. Histogram shows size of overlaps generated by random 
sampling of sets of 100 and 92 numbers between 1 and 23,635 (number of genes in the Xenopus 
tropicalis genome). 
 
3.2.4 Putative CIC and FGF regulated target genes selected for validation of RNA-seq data 
Putative CIC and FGF regulated target genes were selected from those upregulated in both the CIC 
knockdown and FGF4 overexpressing embryos for use in validation of the RNA-seq data. To select 
candidate genes, the 44 genes were sorted by decreasing effect size and 4 genes involved in 
relevant processes selected working down from the top of this list (Table 9).  
frzb was selected because of a high effect size, low q value and the fact that it is an antagonist for 
wnt (Kawano and Kypta, 2003), a gene crucial in many developmental processes. frzb is also known 
to be positively regulated by FGF signalling (Branney et al., 2009). fos and fosl1 were identified as 
genes of interest due to high effect sizes and the fact that they encode transcription factors that 
bind Jun family members to form activator protein-1 (AP-1) heterodimers (Angel and Karin, 1991). 
AP-1 mediates FGF and BMP signalling during Xenopus development (Lee et al., 2011). rasl11b was 
chosen as a candidate gene due to a relatively high effect size and low q value out of those identified 
by gene ontology analysis to be involved in the ERK/MAPK cascade. 
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Gene Description 
CIC knockdown FGF4 injection 
q value Effect size q value Effect size 
frzb wnt antagonist 8.35x10-4 4.49 0.0447 3.21 
fos Transcription factor that binds Jun 
family members to form AP-1 
heterodimers which mediate FGF 
and BMP signalling 
1.42x10-12 4.43 7.15x10-17 5.38 
fosl1 Transcription factor that binds Jun 
family members to form AP-1 
heterodimers which mediate FGF 
and BMP signalling 
0.00532 3.09 0.0154 3.00 
rasl11b GTPase involved in MAPK cascade 3.45x10-7 2.60 0.00145 1.99 
Table 9: Candidate genes selected from 44 gene transcripts upregulated in both FGF4 
overexpressing and CIC knockdown Xenopus tropicalis embryos for use in validation of the RNA-
seq data set. Genes selected due to relatively high effect sizes, low q values and involvement in 
relevant biological processes. Genes ordered by CIC knockdown effect size. 
3.2.5 Candidate gene expression in wild type Xenopus tropicalis embryos 
Having identified genes potentially regulated by both CIC and FGF, gene specific in situ hybridisation 
probes were designed and synthesised to determine if the genes are expressed in regions relevant 
to CIC expression and FGF signalling in normal Xenopus tropicalis development. 
FGF is the sole activator of ERK in early Xenopus development (Branney et al., 2009). dpERK can 
therefore be used to indicate the presence of FGF signalling. For example, dpERK is present in the 
early mesoderm surrounding the blastopore at gastrula stage and is particularly enriched dorsally 
(Figure 9a). ERK is also later activated along the dorsal midline in neural tube formation (Figure 9b). 
  
Figure 9: The spatial expression pattern of dpERK in Xenopus analysed using whole mount 
immunohistochemistry with an antibody against dpERK.  (a) gastrula stage 10.5 Xenopus tropicalis, 
vegetal view, (b) neurula stage 18 Xenopus laevis, dorsal view, anterior to left. Black arrow indicates 
early mesoderm and red arrow indicates the neural folds fusing together during neural tube 
formation. 
In situ hybridisation for frzb, fos, rasl11b and fosl1 was carried out at a range of stages of Xenopus 
tropicalis development (Figures 10-13) to visualise their spatial expression patterns. 
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Distinct dots of frzb expression can be seen at one side of the vegetal pole at late blastula stage 
(Figure 10). frzb expression then expands to form a ring around the blastopore during early 
gastrulation with higher levels of expression dorsally. By gastrula stage 11, frzb is only expressed in 
the involuting prechordal mesoderm. At early neurula stage 14, frzb is expressed in the posterior 
presomitic mesoderm on both sides of the dorsal midline.  
 
Figure 10: The spatial expression pattern of frzb during early Xenopus tropicalis development 
analysed using in situ hybridisation. (a) late blastula stage 9, vegetal view (b) early gastrula stage 
10, vegetal view (c) gastrula stage 10.5, vegetal view (d) gastrula stage 11, vegetal to right, (e) early 
neurula stage 14, lateral view, anterior to left. Black arrows indicate dorsal early mesoderm, red 
arrow indicates prechordal mesoderm, and white arrow indicates presomitic mesoderm. Embryos 
staged according to Nieuwkoop and Faber (1994) stages of Xenopus development. 
At late blastula stage, fos is expressed in a ring around the equator of the embryo when viewed 
from the animal hemisphere (Figure 11). During gastrulation, fos is only expressed in the vegetal 
pole in early mesoderm around the blastopore. Expression increases during early gastrulation in a 
ring around the blastopore with particularly enriched expression dorsally. By gastrula stage 11, fos 
expression has become restricted to the dorsal blastopore. At early neurula stage 14, fos is 
expressed along the dorsal midline where the neural tube is forming. 
 
Figure 11: The spatial expression pattern of fos during early Xenopus tropicalis development 
analysed using in situ hybridisation.  (a) late blastula stage 9, animal view, (b) early gastrula stage 
10, vegetal view (c) gastrula stage 10.5, vegetal view, (d) gastrula stage 11, vegetal view, (e) early 
neurula stage 14, dorsal view, anterior to top. Black arrows indicate dorsal early mesoderm, yellow 
arrow indicates the dorsal blastopore and red arrow indicates forming neural tube. Embryos staged 
according to Nieuwkoop and Faber (1994) stages of Xenopus development. 
At late blastula stage, rasl11b is weakly expressed in a ring around the equator of the embryo when 
viewed from the animal hemisphere (Figure 12). Rasl11b is then expressed dorsally in the vegetal 
pole. At gastrula stage 10.5, expression becomes more widespread but remains highest at the 
dorsal blastopore. By stage 11, rasl11b expression forms a neat ring around the blastopore in the 
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early mesoderm. From neurula stage, rasl11b is expressed in the otic vesicles, posterior presomitic 
mesoderm and proctodaeum.  
 
Figure 12: The spatial expression pattern of rasl11b during Xenopus tropicalis development 
analysed using in situ hybridisation.  (a) late blastula stage 9, animal view, (b) early gastrula stage 
10, vegetal view, (c) gastrula stage 10.5, vegetal view, (d) gastrula stage 11, vegetal view, (e) early 
neurula stage 15, dorsal view, anterior to left, (f) early tailbud stage 25, lateral view, anterior to left. 
Black arrows indicate early mesoderm, yellow arrows indicate otic vesicles, white arrows indicate 
presomitic mesoderm and red arrow indicates proctodaeum. Embryos staged according to 
Nieuwkoop and Faber (1994) stages of Xenopus development. 
fosl1 is weakly expressed in the animal pole at stage 9 and 10 (Figure 13). At gastrula stage 10.5, 
fosl1 expression can be seen in the early mesoderm at the dorsal blastopore before becoming more 
widespread around the blastopore region. At early neurula stage 14, fosl1 is expressed in the neural 
plate. 
 
Figure 13: The spatial expression pattern of fosl1 during early Xenopus tropicalis development 
analysed using in situ hybridisation.  (a) late blastula stage 9, animal view, (b) early gastrula stage 
10, animal view, (c) gastrula stage 10.5, vegetal view, (d) gastrula stage 11, vegetal view, (e) early 
neurula stage 14, lateral view, anterior to left. Black arrow indicates dorsal early mesoderm and 
white arrow indicates neural plate. Embryos staged according to Nieuwkoop and Faber (1994) 
stages of Xenopus development. 
As predicted, in situ hybridisation for frzb, fos, rasl11b and fosl1 indicates that the four candidate 
genes are expressed in known regions of FGF activity and CIC expression. 
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3.2.6 CIC knockdown and FGF overexpressing embryos exhibit a similar phenotype 
Having shown that candidate genes are expressed in known regions of FGF signalling in keeping 
with our hypothesis, Xenopus tropicalis embryos were injected with 1ng CIC targeted TALENs 
mRNA, 5pg CSKA-FGF4 or 1nl H2O, for use in validation of the RNA-seq data set.  
 
Figure 14: Wild type, FGF4 overexpresssing and CIC knockdown Xenopus tropicalis embryo 
phenotypes. Late tailbud stage embryos, lateral view, anterior to left. (a) wild type, un-injected 
embryo, (b) embryo injected with 5pg CSKA-FGF4 at the one-cell stage showing FGF4 
overexpression phenotype of loss of head structures and an enlarged proctodaeum, (c) embryo 
injected with 1ng CIC targeted TALENs mRNA at the one-cell stage exhibiting CIC knockdown 
phenotype of reduced eye pigmentation and an enlarged proctodaeum, (d) embryo injected with 
1ng CIC targeted TALENs mRNA at the one-cell stage displaying a more severe CIC knockdown 
phenotype with loss of head structures and an enlarged proctodaeum. Arrows indicate enlarged 
proctodaeum.  
CIC knockdown via TALENs produced phenotypes with varying degrees of severity. CIC knockdown 
embryos exhibited phenotypes ranging from reduced eye pigmentation, a reduction in eye size, eye 
loss, and a reduction or total loss of head structures, in addition to an enlarged proctodaeum. FGF4 
overexpressing embryos appeared similar with an enlarged proctodaeum and a reduction or total 
loss of head structures leading to a posteriorised phenotype (Figure 14). Not all CIC knockdown or 
FGF4 overexpressing embryos successfully completed gastrulation. CIC knockdown embryos had a 
death rate of 32.3% (21/65) which was higher than FGF4 overexpressing embryos at 20.7% (24/116) 
and un-injected embryos at 7.1% (5/70) (Table 10). 
Xenopus tropicalis embryos Alive Dead 
CIC knockdown 44 21 
FGF4 overexpression 92 24 
Un-injected 65 5 
Table 10: Death rates of injected Xenopus tropicalis embryos. Death rates of un-injected embryos 
and embryos injected with 1ng CIC targeted TALENs mRNA or 5pg CSKA-FGF4 at the one-cell stage. 
Page | 43  
 
3.2.7 Validation of RNA-seq data 
In order to validate the RNA-seq data set, RT-PCR was carried out using primers for the target genes 
on RNA extracted from CIC knockdown, FGF4 overexpressing, H2O injected and un-injected control 
embryos flash frozen at neurula stage 14. 
Fos, fosl1 and rasl11b bands appeared more intense for CIC knockdown and FGF4 injected embryo 
cDNA compared to H2O injected and un-injected controls (Figure 15). However RT-PCR bands for 
frzb were not more intense in CIC knockdown and FGF4 overexpressing embryos compared to 
controls.  
 
Figure 15: RT-PCR for target gene expression in CIC knockdown, FGF4 injected, H2O injected and 
un-injected Xenopus tropicalis embryos. RT-PCR carried out using gene specific primers for fos, 
fosl1, frzb, rasl11b and L8 (as a loading control) on RNA extracted from neurula stage 14 Xenopus 
tropicalis embryos injected with 1ng CIC targeted TALENs RNA, 5pg CSKA-FGF4 or 1nl H2O, and un-
injected embryos.  
3.2.8 Enrichment of CIC binding sites 
CIC binds octameric T(G/C)AATG(A/G)A sites in promoters and enhancers via its HMG-box domain 
to repress target gene transcription. In order to determine whether CIC binding sites are enriched 
around the genomic loci of target genes, MEME suite 5.0.5 (http://meme-suite.org/tools/ame) was 
used to analyse motif enrichment for the target genes and 1004 shuffled control sequences using 
Fisher’s exact test (Table 10). Enrichment of CIC binding sites was analysed within 100 and 200 base 
pairs upstream and downstream of each target gene’s transcribed sequence. The input sequence 
was then expanded to include DNA sequences upstream and downstream up to adjacent genes, as 
regulatory units can be distant from target transcriptional units.  
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CIC binding sites were enriched within 200 base pairs of the transcribed region for fos, fosl1 and 
frzb. When a greater region of DNA sequence up to adjacent genes was included, only fos and frzb 
were identified as genes with enriched CIC binding sites and the number of randomly shuffled 
control sequences with enriched CIC binding sites (false positives) was also lower. Putative CIC 
binding sites are located upstream of the transcribed region for fos and within the first intron 
(Figure 16). Binding motifs were more spread out throughout the gene sequence for fosl1 and frzb. 
Input sequences True Positives False Positives 
Transcribed sequence + 100bp 
upstream and downstream 
3/4 – fos, fosl1 and frzb (75%) 87/1004 (8.7%) 
Transcribed sequence + 200bp 
upstream and downstream 
3/4 – fos, fosl1 and frzb (75%) 
 
87/1004 (8.7%) 
Sequence up to adjacent gene 
sequences 
2/4 – fos and frzb (50%) 31/1004 (3.1%) 
Table 11: Motif enrichment analysis of CIC binding sites. Enrichment of the T(G/C)AATG(A/G)A 
motif for fos, fosl1, frzb and rasl11b and 1004 control sequences using Fisher’s exact test.  
 
 
Figure 16: Schematic representation of putative CIC binding site locations within the fos, fosl1 
and frzb genes.  Orange circles indicate locations of CIC binding motif (T(G/C)AATG(A/G)A). Light 
blue rectangles indicate 5’ and 3’ UTRs and dark blue rectangles represent coding sequences. 
3.3 Discussion 
3.3.1 CIC knockdown and FGF overexpressing embryos possess similar transcriptomes  
RNA-seq data showed a statistically significant overlap between changes in gene expression in 
Xenopus tropicalis embryos injected with FGF4 and CIC targeted TALENs with the probability of 
observed overlaps occurring by chance p < 0.00001. Not all genes were significantly upregulated or 
downregulated in both sets of embryos as CIC may also function in other pathways independently 
of FGF. For example, ERK is activated in the wound response (Dieckgraefe et al., 1997) and may 
relieve CIC transcriptional repression of genes required for this FGF independent process following 
injury. Additionally, out of 88 genes significantly upregulated in FGF4 overexpressing embryos, 37 
were not upregulated in CIC knockdown embryos. This may be due to the fact that FGF signal 
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transduction occurs via 3 main pathways, only one of which involves the ERK/MAPK cascade 
(Schlessinger, 2000). Consequently, we would expect the transcriptome for the two sets of embryos 
to be similar but not identical. The statistically significant overlap observed supports the notion that 
CIC operates in the same pathway as FGF.  
3.3.2 Gene ontology enrichment analysis  
PANTHER gene ontology enrichment analysis revealed that genes significantly upregulated in FGF4 
injected embryos are involved in very relevant biological processes such as the transmembrane 
receptor protein tyrosine kinase signalling pathway, cellular process, ERK/MAPK cascade, 
intracellular signal transduction and developmental process. Genes significantly upregulated in CIC 
knockdown embryos were associated with a greater number of biological processes though many 
were also involved in cellular process, ERK/MAPK cascade and intracellular signal transduction. The 
most enriched gene ontology process for CIC knockdown transcripts was cell proliferation. This 
further supports our hypothesis as FGFs are growth factors which control cell proliferation and 
migration via different signal transduction pathways. Cell migration usually involves pathways such 
as Src and p38 MAPK whereas cell proliferation tends to upregulate ERK (Boilly et al., 2000). We 
would expect FGF target genes associated with cell proliferation to be expressed following relief of 
CIC repression via ERK (or in this case inhibited by TALENs knockdown).  
3.3.3 Target genes are expressed in known regions of CIC expression and FGF signalling 
In situ hybridisation for these genes at various stages of Xenopus tropicalis development showed 
that they are expressed in regions of known CIC and FGF activity. All 4 genes selected as candidate 
genes potentially regulated by both CIC and FGF signalling were expressed in the early mesoderm 
surrounding the blastopore during gastrulation. FGF2, FGF3, FGF4, FGF8 and FGF20 are expressed 
in this ring of early mesoderm around the blastopore during gastrulation (Christen and Slack, 1997; 
Lombardo et al., 1998; Lea et al., 2009). The target genes, both isoforms of CIC, and FGF4 are all 
particularly enriched at the dorsal blastopore lip during gastrulation (King, 2019; Isaacs et al., 1995). 
As the sole activator of ERK in early Xenopus development (Branney et al., 2009), FGF signalling in 
the early mesoderm may lead to relief of CIC transcriptional repression of FGF target genes in this 
region via dpERK-CIC interactions. Other genes previously established to be upregulated by FGF 
signalling such as Cdx4 (Keenan et al., 2006), MyoD (Fisher et. al, 2002) and brachyury (Smith et al., 
1991) are also expressed in this region in gastrula stage 10.5 Xenopus embryos.  
Candidate genes frzb and rasl11b are expressed in the presomitic mesoderm on both sides of the 
dorsal midline from early neurula stage. Presomitic mesoderm gives rise to somites and expresses 
Page | 46  
 
high levels of FGF8 to maintain the cells in an immature state posteriorly (Delfini et al., 2005). FGF 
signalling in this region may prevent CIC inhibiting rasl11b and frzb expression at this point in 
development. Both CIC-L and CIC-S show striated expression at tailbud stage indicating expression 
within somites (King, 2019). In situ hybridisation of rasl11b also showed staining on the ventral side 
in the proctodaeum, which gives rise to the anus. Overexpression of FGF4 in Xenopus laevis 
embryos leads to loss of anterior structures and an enlarged proctodaeum (Isaacs et al., 1994) so 
FGF signalling may regulate transcription of genes such as rasl11b in this region. rasl11b is also 
expressed in the developing otic vesicles where CIC-L, CIC-S, FGF2 and FGF10 and FGF2 are 
expressed (King, 2019; Lea et al., 2009; Branney et al., 2009). fosl1, CIC-L and CIC-S are all expressed 
in the neural plate where FGFR activity is required for neural induction (Delaune et al., 2005).  
If FGF is responsible for regulation of CIC expression, FGF and CIC must be expressed at the same 
time in FGF responsive cells. FGF1, FGF2, FGF13, FGF22 and CIC-L are maternally expressed in early 
development (Lea et al., 2009). Both CIC isoforms are expressed at the marginal zone in the early 
mesoderm during early gastrulation (King, 2019), as are FGF4 and FGF8 (Lea et al., 2009). CIC 
expression becomes more widespread during development to include regions of known FGF 
signalling such as the dorsal somites, neural tissue, otic vesicles and branchial arches (King, 2019). 
Candidate genes upregulated in CIC knockdown and FGF4 overexpressing embryos are expressed 
in regions of both CIC and FGF expression. Consequently, signalling pathways involving both FGF 
and CIC may well regulate their expression.  
3.3.4 CIC knockdown and FGF overexpressing embryos exhibit similar phenotypes 
Targeting of the CIC gene by TALENs results in loss of head structures ranging from complete head 
loss to reduced eye pigmentation in Xenopus tropicalis embryos. These phenotypes are in keeping 
with previous observations by Michael King (2019) due to the mosaic nature of TALENs (Lei et al., 
2012). CIC knockdown embryos resembled the posteriorised phenotype with an enlarged 
proctadaeum previously observed in FGF4 and FGF8 overexpressing embryos (Isaacs et al., 1994). 
The fact that CIC knockdown and FGF overexpressing embryos exhibit similar phenotypes supports 
our hypothesis that CIC operates in the same pathway as FGF.  
3.3.4 Validation of RNA-seq data 
RT-PCR on RNA extracted from CIC knockdown, FGF4 overexpressing and water injected Xenopus 
tropicalis embryos produced more intense bands for fos, fosl1 and rasl11b in both CIC knockdown 
and FGF4 injected embryos. However the intensity of bands may not directly relate to input 
quantity due to the fact that a non-quantitative endpoint PCR was carried out. This experiment was 
Page | 47  
 
only carried out once and more quantitative results could be obtained in the future through repeats 
using q-PCR. Whole-mount in situ hybridisation could also be utilised to visualise changes in gene 
expression following FGF4 overexpression or CIC knockdown.  
Many of the genes identified as being significantly upregulated in both CIC knockdown and FGF 
overexpressing embryos have previously been linked to positive regulation by FGF signalling. 
Consequently, it was expected that the candidate genes would show differential expression in FGF 
overexpressing embryos compared to water-injected controls in RT-PCR. For example, the spatial 
expression of frzb is dramatically reduced by the presence of dominant negative FGFR4 (Branney et 
al., 2009), and expression of both fos and fosl1 were shown to be increased in microarray analysis 
of bovine ovarian granulosa cells treated with FGF8 (Jiang et al., 2013). During mesoderm induction, 
FGF2 treatment of Xenopus animal cap explants lead to increased AP-1 (c-Fos and c-Jun 
heterodimer) activity (Kim et al., 1998). Although AP-1 activity has been associated with FGF 
signalling, this is the first time linking FGF to the transcriptional regulation of fos. This is also the 
first study to show localised expression of fos in the developing amphibian embryo.  
Other genes upregulated in the RNA-seq for both conditions but not selected for RT-PCR analysis 
have also been previously associated with FGF signalling. For example, FGF23 induces phosphaturia 
in proximal tubular epithelial cells by activating SGK1 via ERK (Andrukhova et al., 2012); FGF2 and 
Wnt3a have been shown to modulate expression of Rho activator fgd3 in rat chondrosarcoma 
chondrocytes (Buchtova et al., 2015); and treatment with FGF2 increases mmp1 expression in 
primary human osteoarthritis chondrocytes (Nummenmaa et al., 2015). This suggests that the 
genes highlighted in the RNA-seq were upregulated as described. 
3.3.5 CIC binding site enrichment 
CIC binding sites are enriched within 200bp of the transcribed sequence for fos, fosl1 and frzb. This 
indicates that there are a greater number of sites available for CIC binding around the genomic 
locus for these genes compared to control sequences. CIC may bind enhancers or promoters in 
these regions in order to repress transcription of these FGF target genes. Inclusion of DNA 
sequences up to adjacent genes led to identification of only fos and frzb as genes with enriched the 
CIC binding motif and fewer false positives suggesting that binding sites are definitely enriched in 
these regions.  
CIC binding sites were not found to be enriched around the genomic locus for rasl11b using MEME 
suite 5.0.5. Rasl11b had the lowest effect size out of selected candidate genes from the CIC 
knockdown RNA-seq data at 2.60, though this was still relatively high. It was predicted that rasl11b 
Page | 48  
 
would show enriched binding sites due to the gene being identified from the RNA-seq, expressed 
in regions of known CIC activity and upregulated in CIC knockdown embryos via RT-PCR. CIC may 
bind enhancers further away from the transcribed rasl11b sequence to regulate its expression.  
The fact that the CIC knockdown phenotype resembles that of FGF overexpression, along with the 
statistically significant overlap between genes upregulated or downregulated in the 2 sets of 
embryos, and that genes are expressed in known regions of CIC and FGF activity supports the 
hypothesis that CIC and FGF do function in the same pathway, though further experiments are 
required to solidify this link. 
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Chapter 4: Manipulation of FGF and ERK signalling pathways in 
Xenopus laevis 
4.1 Introduction 
As discussed in the introduction (Chapter 1), we hypothesise that transcription of a subset of FGF 
target genes, and genes involved in the wound response, rely on ERK mediated relief of CIC 
transcriptional repression. In Drosophila, relief of CIC repression is carried out via different 
mechanisms depending on the RTK signalling pathway activated. Activation of ERK by Torso 
signalling in the embryonic poles leads to degradation of CIC whereas EGFR signal transduction via 
ERK in the ovarian follicle induces nuclear export and partial relocalisation of CIC to the cytoplasm 
(Jimenez et al., 2000; Andreu, Ajuria et al., 2012). Consequently, one of these mechanisms may also 
be utilised in the ERK mediated wound response and FGF signal transduction. 
The first intracellular event associated with wounding is a rapid influx of calcium ions (Ca2+) which 
radiates out from the site of injury through several rows of cells depending on the severity of the 
wound (Drumheller and Hubbell, 1991). Calcium activates Rho as well as MAPKs such as ERKs, c‐
jun‐N‐terminal protein kinases (JNKs) and the p38 kinases via Ras (Whitmarsh and Davis, 1996; 
Benink and Bement, 2005; Sosnowski et al., 1993). Activation of ERK leads to repression of 
phosphoinositide 3-kinase (PI3K) and subsequently further activation of Rho, which phosphorylates 
myosin-2 (Li et al., 2013; Kimura et al., 1996). The influx of extracellular calcium and Rho GTPase 
activity are required for assembly of a contractile actomyosin cable around the wound site, which 
aids closure by drawing the edges together like a ‘purse string’ (Figure 17) (Bement et al., 1999; 
Martin and Lewis, 1992). Healing of lens epithelial monolayers is inhibited by the presence of U0126 
(MAPKK/MEK inhibitor that prevents activation of ERK1/2) indicating that ERK activation is also 
crucial for initiation of the wound response (Wang et al., 2003).  
In addition to Rho activation in the wound response, dpERK has also been linked to transcription of 
immediate early response gene fos (Dieckgraefe and Weems, 1999). Immediate early response 
genes (IEGs) such as fos and early growth response (Egr)-1 can be transcribed within minutes of 
stimulation (Bahrami and Drablos, 2016). This rapid response is possible due to the fact that IEG 
transcription does not require protein synthesis as the proteins and transcription factors needed 
are already available in the cell (Herschman, 1991). Expression of fos has been reported in 
epidermal wound edge cells and superficial exposed wound mesenchymal cells in chick and rodent 
model organisms within 15 minutes of wounding (Martin et al., 1994), and fos expression in IEC-6 
monolayers peaks 20 minutes after mechanical wounding (Dieckgraefe et al., 1997). Fos binds Jun 
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transcription factors to form AP-1 heterodimers which have been associated with cell motility, 
wound re-epithelialisation and regulation of wound healing genes when induced in the wound 
response (Figure 17) (Tran et al., 1999; Yates and Rayner, 2002; Martin et al., 1994). ERK activation, 
fos and Egr-1 expression, and wound healing is reduced or completely inhibited by MAPKK inhibitor 
PD-98059 (Dieckgraefe and Weems, 1999). CIC may therefore play a role in the transcriptional 
aspect of the wound response downstream of dpERK.  
 
Figure 17: Schematic diagram of the hypothesised role of CIC within phase 1 of the wound 
response. 
The aims of this chapter are: 
 Determine if CIC is degraded or relocated to the cytoplasm following activation of FGF 
signalling 
 Investigate ERK activation and fos transcription in the wound response over time in 
Xenopus  
 Determine if CIC is degraded or relocated to the cytoplasm in the wound response 
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4.2 Results 
4.2.1 Capicua expression and ERK activation in the presence and absence of FGF signalling 
In order to determine whether CIC is degraded or relocated to the cytoplasm in the presence of 
FGF, Xenopus laevis embryos were unilaterally injected at the 2-cell stage with 50pg or 100pg amino 
terminus myc-tagged Mus musculus CIC-S mRNA (Kim et al., 2013; King, 2019), with or without 10pg 
FGF4 mRNA. Immunostaining for dpERK was carried out to indicate ERK activation, and 
immunostaining for myc undertaken to show presence of myc-CIC. 
 
Figure 18: Immunostaining for dpERK and myc on Xenopus laevis embryos injected with myc-CIC 
mRNA or myc-CIC + FGF4 mRNA.  Early gastrula stage 10.5 Xenopus laevis embryos unilaterally 
microinjected at the 2-cell stage with (a) 50pg myc-CIC mRNA (b) 50pg myc-CIC + 10pg FGF4 mRNA 
(c) 100pg myc-CIC mRNA (d) 100pg myc-CIC + 10pg FGF4 mRNA, arrows indicate 2 significantly more 
stained embryos. 10 embryos per treatment. Animal view.  
Page | 52  
 
ERK was activated in the animal pole of embryos overexpressing FGF due to activation of the FGF 
signalling pathway (Figure 18b and 18d).  
Staining for myc appears more intense in 10 embryos injected with 50pg myc-CIC + 10pg FGF4 
(Figure 18b) than 50pg myc-CIC alone (Figure 18a). 2 out of 10 embryos injected with 100pg myc-
CIC + 10pg FGF4 and immunostained for myc (Figure 18d) were clearly more stained than 100pg 
myc-CIC alone (Figure 18c). There was no notable difference in staining between the other 8 
embryos (Table 12). 
 Number of embryos 
More intense staining when  
co-injected with 10pg FGF 
No difference in staining with or 
without co-injection of 10pg FGF 
50pg myc-CIC  10 0 
100pg myc-CIC 2 8 
Table 12: Difference in myc immunostaining between embryos injected with myc-CIC or myc-CIC 
and FGF. Number of embryos showing more intense or no difference in staining when co-injected 
with 10pg FGF alongside 50pg or 100pg myc-CIC. 10 embryos per treatment. 
In order to see if higher quantities of CIC and FGF4 had the same effect, a similar experiment was 
carried out with 10 Xenopus laevis embryos injected with 500pg myc-CIC mRNA and 10 co-injected 
with 500pg myc-CIC mRNA + 20pg CKSA-FGF4. The CSKA plasmid construct was used as it was 
hypothesised that not enough FGF was being translated for a level of ERK activation sufficient to 
degrade or relocate the high level of myc-CIC being expressed. Use of the plasmid meant that new 
mRNA continued to be made while injected FGF mRNA would have decayed away.  
ERK was activated in a small region where FGF was overexpressed in myc-CIC and CSKA-FGF4 
injected embryos (Figure 19c).  
Myc staining looks nuclear in embryos injected with and without CSKA-FGF4 (Figure 19).  
Myc staining was less intense in embryos co-injected with CSKA-FGF4 compared to myc-CIC alone. 
ImageJ was utilised to determine percentage area stained with a mean of 13.71% for FGF expressing 
embryos compared to 35.39% for those injected with only myc-CIC (Table 13, n=5). An un-paired T 
test showed that the reduction in percentage staining was statistically significant with a p value < 
0.000001 (Figure 20) 
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Figure 19: Immunostaining for dpERK and myc on Xenopus laevis embryos injected with myc-CIC 
mRNA or myc-CIC mRNA + CSKA-FGF4.  Early gastrula stage 10.5 Xenopus laevis embryos 
unilaterally microinjected at the 2-cell stage with (a, b) 500pg myc-CIC mRNA (c, d) 500pg myc-CIC 
mRNA + 20pg CSKA-FGF4. 10 embryos per treatment. Animal view.  
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Percentage area stained 
Myc-CIC Myc-CIC + FGF 
1 38.14 11.19 
2 33.69 12.01 
3 36.70 14.54 
4 36.93 14.87 
5 31.47 15.96 
Mean 35.39 (SEM= 1.22)  13.71 (SEM= 0.90) 
Table 13: Percentage area stained in myc-CIC and myc-CIC + FGF injected embryos. 500pg myc-
CIC mRNA and 500pg myc-CIC mRNA + 20pg CSKA-FGF4 injected embryos immunostained for myc 
at gastrula stage 10.5 and analysed using ImageJ. n=5 per treatment. SEM= standard error of the 
mean. 
 
Figure 20: Percentage area stained in myc-CIC and myc-CIC + FGF injected embryos. 500pg myc-
CIC mRNA and 500pg myc-CIC mRNA + 20pg CSKA-FGF4 injected embryos immunostained for myc 
at gastrula stage 10.5 and analysed using ImageJ. n=5 per treatment. p= 0.0000006. Error bars 
indicate standard error of the mean. 
4.2.2 Western blot analysis of myc-CIC and FGF expressing embryos  
A western blot for dpERK and total ERK was carried out on 500pg myc-CIC, 500pg myc-CIC + 20pg 
CSKA-FGF4 and un-injected Xenopus laevis embryos in order to show activation of ERK by FGF 
(Figure 21). 
dpERK is present in injected and un-injected embryos as ERK is activated by endogenous FGF 
signalling in the early mesoderm surrounding the blastopore at the vegetal pole at this stage of 
development. Higher levels of dpERK are seen in FGF overexpressing embryos compared to un-
injected and myc-CIC injected embryos. ImageJ analysis showed that the relative density of dpERK 
bands for myc-CIC and myc-CIC + CSKA-FGF4 injected embryos are 2.08 and 3.81 respectively when 
normalised to loading control and un-injected embryos. 
 
*** 
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Figure 21: Western blot detecting dpERK and total ERK in Xenopus laevis.  Embryos unilaterally 
injected with 500pg myc-CIC mRNA or 500pg myc-CIC mRNA + 20pg CSKA-FGF4 at the 2-cell stage, 
or un-injected. 5 embryos were collected at gastrula stage 10.5 for each condition and protein for 
approximately 1 embryo loaded for each.  
In order to obtain a more quantitative result than immunostaining, western blots were carried out 
with the aim of determining if there was a reduction of overall levels or size shift in myc-CIC protein. 
A change in protein size would indicate partial degradation or proteolytic cleavage of CIC following 
FGF signalling. Due to the fact that CIC is a large protein with a molecular weight of 250kDa, various 
conditions were tested to optimise transfer of the protein. SDS-PAGE gels were made with 7.5% 
and 7% acrylamide, various concentrations of sample protein loaded, and gels run for increased 
lengths of time. Transfer buffer was altered to include 0.05% SDS instead of 10% methanol and 
proteins transferred overnight at 30V at 4°C. Anti-myc antibodies were used at a 1:4000 and 1:5000 
dilution and 2 different antibodies tested. Unfortunately, no clear bands were observed using any 
of these conditions. Ponceau S staining of the membrane and Coommassie blue staining of the gel 
also revealed no bands.  
4.2.3 ERK activation and fos transcription in the wound response 
In order to investigate ERK activation and gene transcription in the wound response, wild type 
Xenopus laevis embryos were wounded at late neurula stage 20 with a tungsten needle. 
Immunostaining for dpERK was carried out to indicate ERK activation and in situ hybridisation 
undertaken to show fos expression.  
ERK is activated extremely rapidly post-wounding with dpERK expression radiating across the 
embryo from the wound site after 5 minutes (Figure 22A). The presence of dpERK is transient with 
no staining at the wound site after 60 minutes. 
fos is rapidly and transiently expressed following activation of ERK at the wound site (Figure 22). 
Transcription of fos takes longer than ERK activation post-wounding with expression beginning to 
show at 10 minutes post-wounding and strong expression at 30 minutes. fos is no longer expressed 
at the wound site 120 minutes after wounding and the embryo appears completely healed and scar-
free. 
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Figure 22: Xenopus laevis embryos wounded at late neurula stage 20 and fixed at a range of time 
points post-wounding for immunostaining for dpERK and in situ hybridisation of fos. (A) 
Immunostaining with an antibody against dpERK, 6 embryos per time point (B) In situ hybridisation 
of fos, 10 embryos per time point. Lateral view, anterior to left. 
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4.2.4 Capicua expression and fos transcription in the wound response 
In order to determine if CIC is degraded or relocated to the cytoplasm following ERK activation in 
the wound response, Xenopus laevis embryos were unilaterally injected at the 2-cell stage with 
500pg myc-CIC mRNA. 14 embryos were wounded at the site of injection at early gastrula stage 
10.5 and fixed 30 minutes post-wounding. Early gastrula stage was chosen so that results would be 
comparable to those obtained in Figure 19. Immunostaining for myc was carried out to visualise 
myc-CIC expression in 7 wounded and 10 control embryos. In situ hybridisation for fos was also 
carried out to see if there was a difference in fos expression between 7 myc-CIC expressing and 7 
un-injected embryos in the wound response. 
Myc staining was less intense in wounded myc-CIC injected embryos (Figure 23b) compared to 
controls (Figure 23a). ImageJ was utilised to determine percentage area stained with a mean of 
9.19% for wounded myc-CIC injected embryos compared to 35.39% for control myc-CIC embryos 
(Table 14, n=5). An un-paired T test showed that the reduction in percentage staining was 
statistically significant with a p value < 0.00001 (Figure 24) 
Two out of six un-injected embryos showed stronger fos expression at the wound site (Figure 23c) 
compared to six myc-CIC injected embryos (Figure 23d). However, there was not a detectable 
difference in the other embryos, and they did not all remain intact during the in situ hybridisation 
process.  
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Figure 23: Immunostaining for myc and in situ hybridisation for fos in wounded and control myc-
CIC expressing or un-injected Xenopus laevis embryos.  (a) Immunostaining for myc in early 
gastrula stage Xenopus laevis embryos unilaterally injected at the 2-cell stage with 500pg myc-CIC 
mRNA (b) Immunostaining for myc in Xenopus laevis embryos unilaterally injected at the 2-cell stage 
with 500pg myc-CIC mRNA then wounded at the site of injection at early gastrula stage 10.5 and 
fixed 30 minutes post-wounding (c) in situ hybridisation for fos in un-injected Xenopus laevis 
embryos wounded at early gastrula stage 10.5 and fixed 30 minutes post-wounding (d) in situ 
hybridisation for fos in Xenopus laevis embryos unilaterally injected at the 2-cell stage with 500pg 
myc-CIC then wounded at the site of injection at early gastrula stage 10.5 and fixed 30 minutes 
post-wounding. Animal view. 
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 Percentage area stained 
Myc-CIC Wounded myc-CIC 
1 38.14 12.40 
2 33.69 8.61 
3 36.70 6.78 
4 36.93 13.16 
5 31.47 5.00 
Mean 35.39 (SEM= 1.22) 9.19 (SEM= 1.58) 
Table 14: Percentage area stained in wounded and control myc-CIC injected embryos. 500pg myc-
CIC mRNA injected embryos immunostained for myc at gastrula stage 10.5 and analysed using 
ImageJ. n=5 per treatment. SEM= standard error of the mean. 
 
Figure 24: Percentage area stained in wounded and control myc-CIC injected embryos. 500pg 
myc-CIC mRNA injected embryos immunostained for myc at gastrula stage 10.5 and analysed using 
ImageJ. n=5 per treatment. p= 0.000001. Error bars indicate standard error of the mean.  
4.3 Discussion 
4.3.1 CIC expression is reduced following FGF signalling 
It was predicted that myc-CIC would be degraded in embryos co-injected with FGF4 mRNA however 
Xenopus laevis embryos injected with 50pg and 100pg myc-CIC, with and without 10pg FGF4 mRNA 
did not conclusively show this result. This may be due to the fact that insufficient levels of FGF were 
present to activate enough ERK to completely degrade or relocate non-endogenous myc-CIC. 
Embryos injected with 500pg myc-CIC and 20pg CSKA-FGF4 did however show a reduction in 
staining compared to 500pg myc-CIC injected embryos and staining in both sets of embryos 
appeared nuclear. This suggests that myc-CIC was degraded by activation of ERK in FGF signal 
transduction when a greater amount of FGF4 was expressed for a longer period of time, in a similar 
manner to ERK mediated CIC degradation in the Drosophila Torso pathway (Jimenez et al., 2000). 
However, not all embryos showed the same level of staining indicating that unequal amounts of 
*** 
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FGF4 may have been produced. Mosaic expression is common in amphibians with injection of DNA 
constructs giving rise to some variation in the proportion of expressing cells between individual 
embryos. It is unlikely that the biological effects of FGF4 would be restricted due to the fact that 
FGF4 is a secreted molecule (Isaacs et al., 1994) but it may be worth repeating this experiment in 
the future with a larger number of embryos. In spite of the slight variation between levels of staining 
between embryos, ImageJ analysis and T test results indicate that the FGF4 induced reduction in 
staining was statistically significant. 
Western blots carried out to quantitatively determine whether myc-CIC was partially degraded or 
proteolytically cleaved following activation of FGF signalling did not produce any bands. However, 
the 250kDa CIC protein has been previously observed in western blots for GFP tagged Homo sapiens 
CIC-S mRNA injected Xenopus laevis embryos and is not present in embryos co-injected with FGF8 
mRNA (King, 2019). Embryos injected with GFP-CIC-S mRNA and FGF4 mRNA produced no 250kDa 
protein but instead revealed an 85kDa protein which could be a product of CIC protein degradation 
(King, 2019). This suggests that FGF signalling may be linked to the initiation of CIC protein 
degradation with FGF8 possessing a greater potency than FGF4.  
RTK signalling in Drosophila has also been shown to lead to downregulation of CIC expression so it 
is logical that a similar mechanism may be employed in the FGF RTK pathway. For example, Torso 
signalling in the embryonic poles and EGFR signal transduction in the imaginal wing and eye discs 
both lead to reduced levels of CIC (Jimenez et al., 2000; Tseng et al., 2007). The fact that embryos 
overexpressing FGF show decreased immunostaining for CIC-S and CIC-S protein degradation in 
western blots is in keeping with mechanisms observed in other RTK pathways. This suggests a role 
for FGF mediated regulation of CIC expression levels.  
4.3.2 Fos is expressed rapidly and transiently following ERK activation in the wound 
response 
Activation of ERK at the wound site was rapid and transient with dpERK expressed within 5 minutes 
but gone within the hour. This is in line with previous findings that ERK activation is detectable in 
both superficial and deep wounds by western blot analysis from 2 minutes post-wounding with 
phosphorylation decreased by 1 hour (Li et al., 2013).  
Ca2+ influx and ERK activation have been established as critical components of the first phase of 
wound closure for Rho activation and assembly of the actomyosin cable (Stanistreet, 1982; Wang 
et al., 2003). fos has also been strongly associated with wound healing in multiple species and cell 
cultures. In this study, immediate early response gene fos was expressed at the wound site 
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following activation of ERK with the strongest expression at 30 minutes post-wounding. Previous 
experiments have reported a greater than 30-fold increase in c-Fos mRNA by northern blot analysis 
of wounded IEC-6 cell monolayers peaking at 20 minutes (Dieckgraefe et al., 1997). fos expressed 
at the wound site may play a role in regulating transcription of genes involved in the healing 
process. For example, cells that express c-fos during the wound response subsequently upregulate 
transforming growth factor beta-1 (TGFβ1) mRNA 1 hour post-wounding and secrete TGFβ1 protein 
into the wound mesenchyme (Martin et al., 1994). c-fos may upregulate TGFβ1 at the wound site 
in order to initiate connective tissue contraction of the wound mesenchyme.  
In contrast to this, it has been shown that Xenopus embryos injected with α-amanitin 
(Xenopus polymerase II transcription inhibitor) do not show a significant healing defect indicating 
that transcription is not important for the initial response to wounding (Li et al., 2013). However, 
bioinformatic analysis of four epidermal wound enhancers rapidly activated at Drosophila wound 
sites revealed evolutionarily conserved sequences matching binding sites for Jun/Fos and Grainy 
head (Grh) transcription factors in each (Pearson et al., 2009). Fos, Jun and Grh have been linked to 
epidermal wound repair, barrier development and differentiation in Xenopus and mammals (Ting 
et al., 2005; Yates and Rayner, 2002; Tao et al., 2005) The combination of Fos and Grh may be part 
of an ancient wound-response pathway conserved in both vertebrates and invertebrates, however 
other additional mechanisms have evolved alongside this to result in a similar output.  
Additionally, interference with proteins upstream of wound-induced transcription lead to an 
inhibition of fos transcription. For example, calcium is required for wound-induced transcriptional 
activation of AP-1 via Ras and ERK activation (Tran et al., 1999). c-fos expression, cell motility and 
DNA synthesis are all inhibited by microinjection of a dominant-negative Ras mutant protein 
(Sosnowski et al., 1993). Treatment of wounded keratinocytes with ERK and p38 MAPK inhibitors 
reduces the activity of a response element controlled by AP-1 (Jaakkola et al., 1998).  
4.3.3 CIC expression is reduced in wounded embryos 
As ERK is activated rapidly in the wound response, it was predicted that wounding would lead to a 
decrease in CIC expression as activated ERK has been shown to relieve CIC transcriptional repression 
in multiple species (Jimenez et al., 2012). Myc-CIC-S expression was reduced in wounded embryos 
compared to control embryos injected with the same amount of myc-CIC-S. ImageJ analysis and T 
test results indicate that the wound induced reduction in staining was statistically significant. This 
is in keeping with our hypothesis that CIC is sent for degradation in the ERK mediated wound 
response.  
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As fos is expressed following ERK activation in the wound response (Dieckgraefe et al., 1997) and 
may be transcriptionally regulated by CIC in the FGF signalling pathway (Chapter 3), it was predicted 
that fos expression may also be regulated by CIC in the wound response. It was thought that 
overexpression of CIC may reduce fos transcription at the wound site, however only 2 un-injected 
embryos showed higher fos expression than myc-CIC-S injected embryos. No detectable difference 
in fos expression was observed between the other 5 myc-CIC-S injected and un-injected wounded 
embryos at gastrula stage 10.5. This could be due to the fact that dpERK at the wound site was 
sufficient to relieve CIC repression in the majority of the embryos in spite of the higher level of CIC 
protein expression. 
Another gene strongly activated at wound sites in Drosophila and murine models is growth arrest 
and DNA damage inducible gadd45 (Stramer et al., 2008). Gadd45 mediates activation of the 
p38/JNK pathway via MTK1/MEKK4 kinase following exposure to physiological and environmental 
stressors (Salerno et al., 2012). A cluster of Fos and Grh consensus sites are located upstream of 
the gadd45 transcription start site indicating that fos expression may be important for regulation 
of other wound healing genes (Pearson et al., 2009). Both fos and gadd45a were upregulated in CIC 
knockdown and FGF overexpressing embryos (Chapter 3). As CIC expression is reduced in wounded 
embryos following rapid activation of ERK, and wound-associated genes have been identified as 
potential targets of CIC regulation, ERK mediated relief of CIC repression via wounding may allow 
transcription of fos and subsequently other wound healing enhancers such as gadd45a.  
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Chapter 5: General discussion 
5.1 Summary 
Despite extensive understanding of FGF signal transduction, the specific mechanism responsible for 
regulation of target gene transcription is still not fully understood. We hypothesise that 
transcription of a subset of FGF target genes, and genes involved in the wound response, rely on 
ERK mediated relief of CIC transcriptional repression.  
Findings in this study support the notion that CIC operates in the same pathway as FGF, as CIC 
knockdown and FGF overexpressing embryos exhibit similar phenotypes and possess similar 
transcriptomes. CIC expression is reduced following activation of FGF signalling, and previous data 
indicates that CIC protein is partially degraded by injection of FGF4 mRNA and completely degraded 
by FGF8 (King, 2019). Additionally, 75% of the putative CIC and FGF regulated genes further 
analysed have enriched CIC binding sites around their genomic locus. 
In keeping with our hypothesis, CIC expression is also reduced in wounded embryos. fos and 
gadd45a are both expressed in the wound response (Martin et al., 1994; Dieckgraefe et al., 1997; 
Stramer et al., 2008) and were also upregulated in CIC knockdown embryos. Consequently, wound-
induced ERK mediated relief of CIC repression may allow transcription of fos and subsequently 
other wound healing enhancers such as gadd45a.  
5.2 The role of Capicua in development and disease 
5.2.1 Fibroblast growth factor signalling 
FGF signalling is crucial for the initiation and regulation of multiple developmental processes 
including gastrulation, neural and mesoderm induction, limb development and anteroposterior 
patterning (Rossant et al., 1997; Slack et al., 1996; ten Berge et al., 2008). Correct regulation of this 
signalling pathway is extremely important for normal development as several FGFR mutations lead 
to cancer or skeletal abnormalities such as craniosynostosis, achondroplasia and Crouzon syndrome 
(Teven et al., 2014). Misregulation of FGF ligands can also lead to a range of disorders including 
hypophosphatemic rickets, lacrimo-auriculo-dento-digital syndrome and Kallmann syndrome 
(White et al., 2000; Milunsky et al., 2006; Falardeau et al., 2008). Furthering our understanding of 
the molecular mechanisms involved in FGF dependent transcription will be a significant benefit in 
fields such as stem cell research, regenerative medicine and treatment of cancers associated with 
misregulated FGF signalling. If CIC functions as a transcriptional repressor downstream of FGF, 
Torso and EGFR, it may also be an important component of other RTK signalling pathways. 
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5.2.2 Capicua and cancer 
FGFR mutations are associated with a number of cancers due to the fact that correct FGF signalling 
is important for appropriate cell proliferation and angiogenesis (Turner and Grose, 2010). CIC is a 
known tumour suppressor gene as it is a critical regulator of cell proliferation.  
Most cancer-causing CIC mutations identified so far are missense mutations in the HMG-box 
domain which is responsible for DNA binding (Tanaka et al., 2017). Missense and insertion/deletion 
mutations in the C1 motif are the next most common as the C1 domain normally interacts with the 
HMG-box to stabilise DNA binding (Fores et al., 2017). Loss of function mutations such as these are 
frequently observed in human neoplasms such as oligodendroglioma as loss of repression of target 
genes such as the PEA3 family promotes cell proliferation and migration (Tanaka et al., 2017). 
Alternatively, if CIC fuses with DUX4, the chimera is a potent transcriptional activator which 
significantly upregulates PEA3 family transcription factors (such as Etv1, Etv4 and Etv5) and 
Ccnd1/d2 resulting in Ewing-like sarcoma development (Kawamura-Saito et al., 2006; Yoshimoto et 
al., 2017). Chromosomal translocation of PEA3 transcription factors is also associated with 
development of Ewing and prostate tumours through the upregulation of matrix metalloproteases 
and other targets involved in extracellular matrix remodelling and metastatic behaviour (de Launoit 
et al., 2006; Oh et al., 2012). As PEA3 genes are known mediators of FGF signalling and their 
transcription is repressed by CIC in the absence of ERK signalling (Garg et al., 2018; Dissanayake et 
al., 2011), furthering our understanding of this pathway may allow development of improved 
cancer treatments in the future.  
A common target of molecular targeted therapy is the RTK-Ras-ERK/MAPK pathway. Unfortunately, 
acquired resistance for these therapies occurs frequently so downstream modifiers such as CIC have 
the potential to be utilised as effective alternative targets (Schmitt et al., 2016).  
5.2.3 Capicua and neurodegenerative disease 
In vertebrates, the CIC ATXN1 binding domain enables binding of ATAXIN-1 (ATXN1) or ATAXIN-1-
LIKE (ATXN1L) proteins to form a protein repressor complex (Lam et al., 2006). In spinocerebellar 
ataxia type 1 (SCA1) patients, a polyglutamine expansion-induced gain of function in ATXN1 results 
in loss of motor co-ordination, slurred speech and cognitive impairments (Zoghbi and Orr, 2009). 
Neurotoxic glutamine expanded ATXN1 binds CIC less efficiently leading to a significantly increased 
level of expression of CIC targets such as Etv1, Etv5 and Ccnd1 due to a reduction in CIC-ATXN1 co-
repressive activity (Crespo-Barreto et al., 2010; Lim et al., 2008). In addition to this, glutamine 
expanded ATXN1 also causes stronger binding of CIC to promoters of certain genes leading to hyper-
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repression of those targets (Fryer et al., 2011). A genetic reduction of CIC levels substantially 
improves the neuropathy, learning and memory of mice expressing glutamine expanded ATXN1. 
Physical exercise also improves the SCA1 phenotype as enhanced EGFR signalling in brainstem 
downregulates CIC in the tissue (Fryer et al., 2011). It has been hypothesised that SCA1, along with 
other neurodegenerative diseases including Huntington, prion and Alzheimer disease, involve both 
increased function of a specific endogenous protein complex, in addition to loss of function of 
another (Lim et al., 2008; Crespo-Barreto et al., 2010). Therefore, understanding the role of ATXN1-
CIC protein complexes and mutations leading to simultaneous loss and gain of function mutations 
may allow discovery of critical pathways involved in polyglutamine expanded neurodegenerative 
pathologies. 
Additionally, in mouse models, the progressive pathogenesis of SCA1 has been shown to require 
the continuous expression of glutamine expanded ATXN1 (Zu et al., 2004). This suggests that 
identification of drugs able to target the mutant ATXN1-CIC complexes in the correct manner may 
allow some degree of functional recovery for SCA1 patients (Zoghbi and Orr, 2009). Consequently, 
it is important that we understand how CIC functions and interacts with other proteins and 
promoters both in normal development and disease conditions to be able to develop effective 
therapeutics. 
5.3 Future work 
This study presents evidence towards a transcriptional regulatory role for CIC for a subset of FGF 
target genes and genes involved in the wound response. Further validation of the RNA-seq data 
using qPCR would provide more quantitative results but could not be carried out within the scope 
of this project. Alternatively, in situ hybridisation for transcripts identified in the RNA-seq could be 
carried out at a range of developmental stages in wild type, CIC knockdown and FGF overexpressing 
embryos, and gene expression compared. 
Repeating the experiment in which immunostaining against myc was carried out on myc-CIC, myc-
CIC + CSKA-FGF4 and wounded myc-CIC expressing embryos to obtain higher numbers of replicates 
would be advantageous in strengthening the reliability of statistics. Additionally, dry transfer of the 
western blot using the iBlot 2 dry blotting system (Thermo Fisher Scientific) with a higher 
concentration of antibody may allow quantitative determination of whether myc-CIC is partially 
degraded or proteolytically cleaved following activation of ERK by FGF signalling or wounding. 
Following on from the encouraging MEME analysis carried out on the 4 genes investigated in this 
study, chromatin immunoprecipitation sequencing (ChIP-seq) with tagged constructs could be 
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utilised to identify global binding sites for CIC to aid identification of other CIC target genes. 
Comparison to the RNA-seq data set could be carried out to determine whether the other 
upregulated transcripts also possess enriched binding sites around their genomic locus. An 
additional approach would be identification of direct binding targets of CIC through electrophoretic 
mobility shift assays (EMSA). 
In this study, wound-induced dpERK and fos expression was investigated following wounding at late 
neurula stage 20 with clear results. Unfortunately, fos expression at the wound site at gastrula stage 
10.5 was not as easily detectable. Consequently, expression of wound-associated genes such as fos 
could be analysed by in situ hybridisation with a greater number of embryos at a later stage of 
development in myc-CIC injected and wild type embryos to contribute to determining whether CIC 
overexpression affects transcription. Use of an additional model such as Zebrafish may further 
confirm these wound healing results. 
5.4 Conclusions and implications 
Evidence presented in this thesis supports the hypothesis that transcription of a subset of FGF 
target genes, and genes involved in the wound response, rely on ERK mediated relief of CIC 
transcriptional repression. Tight regulation of these target genes is essential for normal 
development as misregulation of the FGF signalling pathway and/or CIC repression is associated 
with a range of disorders and cancers. Understanding the molecular mechanisms involved in CIC 
regulated pathways may allow more effective approaches to treatment of developmental 
disorders, neurodegenerative diseases and cancer. Expanding our knowledge of the wound healing 
process may also ultimately lead to the development of new, more effective therapeutics and 
procedures to promote accelerated wound healing. 
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Abbreviations 
AP-1 Activator protein-1 
ATXN1 Ataxin-1 
Xbra Brachyury 
CIC Capicua 
CIC-L Capicua-long isoform 
CIC-S Capicua-short isoform 
Cdx Caudal type homeobox 
Cdc42 Cell division cycle 42 
ChIP-seq Chromatin immunoprecipitation sequencing 
Ccnd1/d2 Cyclin d1/d2 
DAG Diacylglycerol 
DIG Digoxigenin 
dpERK Diphosphorylated ERK 
DUX4 Double homeobox 4 
Dusp6 Dual-specificity phosphatase 6 
ETS E26 transformation-specific transcription factors 
Etv ETS variant transcription factor 
Egr-1 Early growth response-1 
EMSA Electrophoretic mobility shift assay 
EGFR Epidermal growth factor receptor 
ERK extracellular signal-regulated kinase 
FGF Fibroblast growth factor 
FGFR Fibroblast growth factor receptor 
Frs2 Fibroblast growth factor receptor substrate 2 
FGFRL Fibroblast growth factor receptor-like 
GO Gene ontology 
Grb2 Growth factor receptor bound protein 2 
Gab1 Growth factor receptor bound protein 2-associated-binding protein 1 
GDP Guanosine diphosphate 
GTP Guanosine triphosphate 
HSPG Heparin sulphate proteoglycan 
HMG-box High Mobility Group-box 
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Hox Homeobox 
Hkb Huckebein 
JNK c-Jun N-terminal kinases 
KPNA3 Importin α4 
IP3 Inositol-1,4,5-trisphosphate  
IEC Intestinal epithelial cells 
LEC Lens epithelial cells 
MMP Matrix metalloprotease 
MBT Midblastula transition 
MAPK Mitogen-activated protein kinase 
Mek/MAPKK Mitogen-activated protein kinase kinase 
MRS Modified Ringers Solution 
MyoD Myoblast determination protein 1 
NHEJ Non-homologous end joining 
NAM Normal Amphibian Medium 
NLS Nuclear localisation sequence 
p90RSK p90 ribosomal S6 kinase 
PEA3 Polyoma enhancer activator 3 
PI3 Phosphoinositide-3 
PLCγ Phospholipase Cγ 
PCR Polymerase chain reaction 
PANTHER Protein analysis through evolutionary relationships 
AKT/PKB Protein kinase B 
PKC Protein kinase C 
RTK Receptor tyrosine kinase 
SGK1 Serum/Glucocorticoid Regulated Kinase 1 
Sos Son of sevenless 
SCA1 Spinocerebellar ataxia type 1 
SH2 Src homology 2 
SH3 Src homology 3 
Tll Tailless 
TPM Transcripts per million 
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